"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,US,B1,US 7331146 B1,130-807-104-363-860,2008-02-19,2008,US 88119904 A,2004-06-29,US 88119904 A,2004-06-29,Window and door jamb adjustment system,"A window and door jamb adjustment system for accurately installing windows and doors and providing for later adjustment of the same. The window and door jamb adjustment system includes a support member attachable to a building frame, an alignment member slidably attached to the support member and attachable to an extension jamb, a door or window, and a threaded shaft attached to the support member and threadably engaging the alignment member. As the threaded shaft is rotated, the rotational motion is converted to linear motion of the alignment member. As the alignment member is moved with respect to the support member, the extension jamb, a door or window, is correspondingly moved inwardly or outwardly for proper alignment with plasterboard.",B3 PRODUCTS INC,BEUTLER WILLIAM A;;BERG GARY O,B3 PRODUCTS INC (2004-06-28),https://lens.org/130-807-104-363-860,Granted Patent,yes,21,24,1,1,0,E06B1/6015;;E06B1/6015;;E06B1/6046;;E06B1/6046,E06B3/96;;E06B1/04,52/204.56;;49/505,1,0,,,"Dean Lumber & Supply, Dean-lunber.com, Website Printout, Jun. 20, 2004, 2 pages.",INACTIVE
2,US,A,US 3486179 A,063-914-052-294-896,1969-12-30,1969,US 3486179D A,1965-10-22,US 50146865 A,1965-10-22,METHOD AND MACHINE FOR MAKING LOCKING FASTENERS,,LAMSON & SESSIONS CO,BEUTLER WARREN E;;JAVORICH WILLIAM J,RUSSELL BURDSALL & WARD CORPORATION (1981-04-08),https://lens.org/063-914-052-294-896,Granted Patent,no,2,4,1,1,0,B21K1/707;;B21K1/707,B21K1/70,10/72,0,0,,,,EXPIRED
3,US,A,US 5733229 A,143-137-413-703-314,1998-03-31,1998,US 38234395 A,1995-02-01,US 38234395 A,1995-02-01,Exercise apparatus using body weight resistance,An exercise machine has a frame that has a base with an upright member. The upright member is formed to have a race to receive wheels to interconnect a second frame to the upright member. A cable and pulley structure interconnects exercise structures to cause movement of the second frame relative to the first frame. A user is positioned on a seat connected to the second frame to resist movement of the second frame relative to the first frame. A butterfly structure is provided that has a mechanical linkage to interconnect the link arms to a butterfly lever rotatably connected to deflect the cable of an associated cable arrangement.,ICON HEALTH & FITNESS INC,DALEBOUT WILLIAM T;;BEUTLER STEVEN J,ICON HEALTH & FITNESS INC (2014-12-16);;OHIO STATE INNOVATION FOUNDATION (2014-11-24);;ICON IP INC (2001-06-29),https://lens.org/143-137-413-703-314,Granted Patent,yes,100,134,2,2,0,A63B21/068;;A63B21/154;;A63B23/0494;;A63B23/1254;;A63B23/1254;;A63B21/068;;A63B21/154;;A63B23/0494,A63B21/00;;A63B21/068;;A63B23/04;;A63B23/12,482/96;;482/135;;482/136;;482/138;;482/139,22,0,,,"Swivel Grip, advertisement received in PTO Jun. 9, 1994, 6 pages.;;The Gravity Edge Assembly Instructions.;;The Gravity Edge Owner s Manual.;;The Gravity Edge Advertising Brochure.;;The Gravity Edge Advertising Slick.;;Exercise for Men Only Advertising Page; Home Gyms, Benches & Lifestyle .;;Expert Advertising Brochure.;;Health Rider Advertising Brochure.;;JCPenney Advertisement for Bodylift CTX, Pro form Treadmill, and Alpine Tracker (1991).;;Pacific Fitness Bodylift 1000 Brochure (1994).;;Pacific Fitness Bodylift 1000 Advertisement, The Home Fitness Buyers Guide, Winter 1994.;;Pro Form Advertisement for the Bodylift, VKR, and Stepper.;;Pro Form Edge 4001 Advertising Brochure (1993).;;Pro Form Edge 4001 Explanatory Brochure.;;Pro Form Edge 2001 Advertising Brochure.;;Pro Form Edge 2001 Features and Benefits Brochure (1991 92).;;Pro Form Bodylift Owner s Manual (1994).;;Pro Form Bodylift Exercise Guide (1994).;;Pro Form Bodylift Brochure.;;Stearns Bench Brochure (Sep. 1992).;;Total Gym Advertisement.;;WESLO Body Focus Brochure (Mar. 16, 1994).",EXPIRED
4,US,A1,US 2012/0215608 A1,053-745-758-455-914,2012-08-23,2012,US 201113033195 A,2011-02-23,US 201113033195 A,2011-02-23,WEB-BASED REWARD POINT SYSTEM,"A web-based reward point system that awards points in the form of web credits to users as a reward for participating in certain online activities. The web credits are stored in a database that contains information about user accounts, web credit award activity and web credit redemption activity. The user is able to redeem web credits by receiving a voucher from the website that contains a unique voucher ID and presenting the voucher to a vendor at a business location of the vendor. The vendor is able to verify the authenticity of the voucher by checking the voucher ID at the website. In exchange for the voucher, the user receives a reward from the vendor. Alternatively, the user can load web credits onto an existing vendor loyalty card or debit/credit card which can be used as currency with the vendor.",PAULOS WILLIAM J;;EPSTEIN JERRY A;;BEUTLER BRADY J,PAULOS WILLIAM J;;EPSTEIN JERRY A;;BEUTLER BRADY J,,https://lens.org/053-745-758-455-914,Patent Application,yes,10,21,1,1,0,G06Q30/02;;G06Q30/02,G06Q30/00,705/14.23;;705/14.39,0,0,,,,DISCONTINUED
5,EP,B1,EP 0712698 B1,076-607-902-160-846,2000-04-05,2000,EP 95308193 A,1995-11-15,US 34175294 A,1994-11-18,Apparatus and method for slitting corrugated paperboard boxes,,MARQUIP INC,SMITTERBERG DEAN W;;NACHTRAB WILLIAM R JR;;KADLECEK DAVID G;;BEUTLER BRUCE H,,https://lens.org/076-607-902-160-846,Granted Patent,yes,5,0,7,7,0,B26D1/02;;B26D1/08;;B26D1/46;;B26D1/54;;B26D7/015;;B26D7/0675;;B26D7/32;;B26D2007/322;;B65H2301/4229;;Y10T83/0476;;Y10T83/6574;;Y10T83/6576;;Y10T83/6582;;Y10T83/707;;Y10T83/7264;;Y10T83/7245;;Y10T83/0448;;Y10T83/148;;Y10T83/7258;;Y10T83/764;;Y10T83/0476;;Y10T83/6574;;Y10T83/6576;;Y10T83/6582;;Y10T83/707;;Y10T83/7264;;Y10T83/7245;;Y10T83/0448;;Y10T83/148;;Y10T83/7258;;Y10T83/764;;B26D7/015;;B26D7/0675;;B26D1/08;;B26D1/02;;B65H2301/4229;;B26D1/54;;B26D7/32;;B26D2007/322;;B26D1/46,B26D1/02;;B26D1/08;;B26D1/46;;B26D1/54;;B26D7/01;;B26D7/06;;B26D7/32,,0,0,,,,EXPIRED
6,EP,A2,EP 0712698 A2,015-380-489-766-96X,1996-05-22,1996,EP 95308193 A,1995-11-15,US 34175294 A,1994-11-18,Apparatus and method for slitting corrugated paperboard boxes,"An apparatus and method for slitting a stack (15) of folded corrugated paperboard boxes utilizes a thin slitting blade (46) mounted for continuous movement through a slitting station and defining a vertical slitting plane. A stack supporting table (26) straddles the slitting blade (46) to support a stack (15) of boxes in a stand-by position above the blade (46). Adjustable upstream and downstream squaring devices (34, 35) are operative to square and center the stack (15) in the cutting plane and a vertically reciprocable ram (66) operates to move the stack (15) and the supporting table (26) downwardly past the blade (46) against a table biasing force to slit the stack (15) into two half-size stacks (47). The squaring devices (34, 35) are operable to re-square the slit half-size (47) prior to conveyance out of the slitting station. The slitting run of the continuous blade (46) operates in a rigid blade holder (66) which is adjustable to compensate for blade wear and to maintain the cutting edge of the blade (46) in a fixed plane.",MARQUIP INC,SMITTERBERG DEAN W;;NACHTRAB WILLIAM R JR;;KADLECEK DAVID G;;BEUTLER BRUCE H,,https://lens.org/015-380-489-766-96X,Patent Application,yes,5,3,7,7,0,B26D1/02;;B26D1/08;;B26D1/46;;B26D1/54;;B26D7/015;;B26D7/0675;;B26D7/32;;B26D2007/322;;B65H2301/4229;;Y10T83/0476;;Y10T83/6574;;Y10T83/6576;;Y10T83/6582;;Y10T83/707;;Y10T83/7264;;Y10T83/7245;;Y10T83/0448;;Y10T83/148;;Y10T83/7258;;Y10T83/764;;Y10T83/0476;;Y10T83/6574;;Y10T83/6576;;Y10T83/6582;;Y10T83/707;;Y10T83/7264;;Y10T83/7245;;Y10T83/0448;;Y10T83/148;;Y10T83/7258;;Y10T83/764;;B26D7/015;;B26D7/0675;;B26D1/08;;B26D1/02;;B65H2301/4229;;B26D1/54;;B26D7/32;;B26D2007/322;;B26D1/46,B26D1/02;;B26D1/08;;B26D1/46;;B26D1/54;;B26D7/01;;B26D7/06;;B26D7/32,,0,0,,,,EXPIRED
7,EP,A3,EP 0712698 A3,128-376-051-870-83X,1996-09-04,1996,EP 95308193 A,1995-11-15,US 34175294 A,1994-11-18,Apparatus and method for slitting corrugated paperboard boxes,"An apparatus and method for slitting a stack (15) of folded corrugated paperboard boxes utilizes a thin slitting blade (46) mounted for continuous movement through a slitting station and defining a vertical slitting plane. A stack supporting table (26) straddles the slitting blade (46) to support a stack (15) of boxes in a stand-by position above the blade (46). Adjustable upstream and downstream squaring devices (34, 35) are operative to square and center the stack (15) in the cutting plane and a vertically reciprocable ram (66) operates to move the stack (15) and the supporting table (26) downwardly past the blade (46) against a table biasing force to slit the stack (15) into two half-size stacks (47). The squaring devices (34, 35) are operable to re-square the slit half-size (47) prior to conveyance out of the slitting station. The slitting run of the continuous blade (46) operates in a rigid blade holder (66) which is adjustable to compensate for blade wear and to maintain the cutting edge of the blade (46) in a fixed plane.",MARQUIP INC,SMITTERBERG DEAN W;;NACHTRAB WILLIAM R JR;;KADLECEK DAVID G;;BEUTLER BRUCE H,,https://lens.org/128-376-051-870-83X,Search Report,yes,5,0,7,7,0,B26D1/02;;B26D1/08;;B26D1/46;;B26D1/54;;B26D7/015;;B26D7/0675;;B26D7/32;;B26D2007/322;;B65H2301/4229;;Y10T83/0476;;Y10T83/6574;;Y10T83/6576;;Y10T83/6582;;Y10T83/707;;Y10T83/7264;;Y10T83/7245;;Y10T83/0448;;Y10T83/148;;Y10T83/7258;;Y10T83/764;;Y10T83/0476;;Y10T83/6574;;Y10T83/6576;;Y10T83/6582;;Y10T83/707;;Y10T83/7264;;Y10T83/7245;;Y10T83/0448;;Y10T83/148;;Y10T83/7258;;Y10T83/764;;B26D7/015;;B26D7/0675;;B26D1/08;;B26D1/02;;B65H2301/4229;;B26D1/54;;B26D7/32;;B26D2007/322;;B26D1/46,B26D1/02;;B26D1/08;;B26D1/46;;B26D1/54;;B26D7/01;;B26D7/06;;B26D7/32,,0,0,,,,EXPIRED
8,US,A,US 5483856 A,184-378-682-679-716,1996-01-16,1996,US 34175294 A,1994-11-18,US 34175294 A;;US 6593593 A;;US 87868192 A,1992-05-05,Apparatus and method for slitting corrugated paperboard boxes,An apparatus and method for slitting a stack of folded corrugated paperboard boxes utilizes a thin slitting blade mounted for continuous movement through a slitting station and defining a vertical slitting plane. A stack supporting table straddles the slitting blade to support a stack of boxes in a stand-by position above the blade. Adjustable upstream and downstream squaring devices are operative to square and center the stack in the cutting plane and a vertically reciprocable ram operates to move the stack and the supporting table downwardly past the blade against a table biasing force to slit the stack into two half-size stacks. The squaring device is operable to re-square the slit half-size stacks prior to conveyance out of the slitting station. The slitting run of the continuous blade operates in a rigid blade holder which is adjustable to compensate for blade wear and to maintain the cutting edge of the blade in a fixed plane. The drum-like pulleys around which the slitting blade runs include a blade bias adjustment device which is used to maintain carefully monitored support of the blade in the blade holder to minimize wear and provide proper blade support along its full slitting run.,MARQUIP INC,SMITTERBERG DEAN W;;NACHTRAB JR WILLIAM R;;KADLECEK DAVID G;;BEUTLER BRUCE H,MARQUIP INC (1994-11-16),https://lens.org/184-378-682-679-716,Granted Patent,yes,8,29,7,7,0,B26D1/02;;B26D1/08;;B26D1/46;;B26D1/54;;B26D7/015;;B26D7/0675;;B26D7/32;;B26D2007/322;;B65H2301/4229;;Y10T83/0476;;Y10T83/6574;;Y10T83/6576;;Y10T83/6582;;Y10T83/707;;Y10T83/7264;;Y10T83/7245;;Y10T83/0448;;Y10T83/148;;Y10T83/7258;;Y10T83/764;;Y10T83/0476;;Y10T83/6574;;Y10T83/6576;;Y10T83/6582;;Y10T83/707;;Y10T83/7264;;Y10T83/7245;;Y10T83/0448;;Y10T83/148;;Y10T83/7258;;Y10T83/764;;B26D7/015;;B26D7/0675;;B26D1/08;;B26D1/02;;B65H2301/4229;;B26D1/54;;B26D7/32;;B26D2007/322;;B26D1/46,B26D1/02;;B26D1/08;;B26D1/46;;B26D1/54;;B26D7/01;;B26D7/06;;B26D7/32,83/23;;83/29;;83/419;;83/420;;83/424;;83/468.6;;83/788,0,0,,,,EXPIRED
9,WO,A1,WO 1995/011608 A1,006-162-486-049-330,1995-05-04,1995,US 9411462 W,1994-10-06,US 14387393 A;;US 17367793 A,1993-10-27,ADJUSTABLE VEHICLE-CARRYING FRAME FOR INSERTION INTO DIFFERENTLY-SIZED CONTAINERS,"An adjustable frame (200) for carrying vehicles between elongate upright sides preferably includes a length-adjusting mechanism (206) for expanding the length of the frame to fit transport contaiers of different sizes, a friction-reducing mechanism (300) for smoother, safer and faster lengthwise adjustment of the respective frame sections, and a door-protecting mechanism including not only the length-adjusting mechanism but also shock-absorbing bumper assemblies (360, 362) for protecting the container door, the frame (200) and the vehicles on the frame through a reduction in the peak level of shock forces generated during collisions between the container door and the frame. Preferably, the adjustable frame (200) has only two sections (212, 214) for faster locking and is configured to flexibly accommodate different vehicle lengths, including by support of a pair of vehicle wheels in a center position on the frame.",G & G INTELLECTUAL PROPERTIES,GEARIN PETER;;HALPIN TERENCE;;PILEGGI JAMES D;;BROWNE MICHAEL P J;;BEUTLER WILLIAM C,,https://lens.org/006-162-486-049-330,Patent Application,yes,8,4,10,10,0,B60P3/07;;B60P3/08;;B61D3/18;;B61D3/20;;B65D88/005;;B65D88/022;;B65D88/121;;B65D88/123;;B65D2585/6867;;B65G2201/0294;;A47F5/00;;B65D88/121;;B65D88/022;;B65D88/123;;B65G2201/0294;;B60P3/08;;B65D88/005;;B60P3/07;;B61D3/20;;B61D3/18;;B65D2585/6867,B60P3/07;;B60P3/08;;B61D3/18;;B61D3/20;;B65D85/68;;B65D88/00;;B65D88/02;;B65D88/12;;B65D90/00,,0,0,,,,PENDING
10,CA,C,CA 2170634 C,189-769-201-108-905,1998-10-27,1998,CA 2170634 A,1994-10-06,US 14387393 A;;US 17367793 A,1993-10-27,ADJUSTABLE VEHICLE-CARRYING FRAME FOR INSERTION INTO DIFFERENTLY-SIZED CONTAINERS,"An adjustable frame (200) for carrying vehicles between elongate upright sides preferably includes a length-adjusting mechanism (206) for expanding the length of the frame to fit transport contaiers of different sizes, a friction-reducing mechanism (300) for smoother safer and faster lengthwise adjustment of the respective frame sections, and a door-protecting mechanism including not only the lengthadjusting mechanism but also shock-absorbing bumper assemblies (360, 362) for protecting the container door, the frame (200) and the vehicles on the frame through a reduction in the peak level of shock forces generated during collisions between the container door and the frame. Preferably, the adjustable frame (200) has only two sections (212, 214) for faster locking and is configured to flexibly accommodate different vehicle lengths, including by support of a pair of vehicle wheels in a center position on the frame.",G & G INTELLECTUAL PROPERTIES,GEARIN PETER;;BROWNE MICHAEL P J;;HALPIN TERENCE;;BEUTLER WILLIAM C;;PILEGGI JAMES D,,https://lens.org/189-769-201-108-905,Granted Patent,no,0,0,10,10,0,B60P3/07;;B60P3/08;;B61D3/18;;B61D3/20;;B65D88/005;;B65D88/022;;B65D88/121;;B65D88/123;;B65D2585/6867;;B65G2201/0294;;A47F5/00;;B65D88/121;;B65D88/022;;B65D88/123;;B65G2201/0294;;B60P3/08;;B65D88/005;;B60P3/07;;B61D3/20;;B61D3/18;;B65D2585/6867,B60P3/07;;B60P3/08;;B61D3/18;;B61D3/20;;B65D85/68;;B65D88/00;;B65D88/02;;B65D88/12;;B65D90/00,,0,0,,,,EXPIRED
11,WO,A3,WO 2004/037373 A3,182-311-704-950-038,2004-07-15,2004,US 0333670 W,2003-10-21,US 42047302 P,2002-10-21,CHEMICAL CHAPERONES AND THEIR EFFECT UPON THE CELLULAR ACTIVITY OF beta-GLUCOSIDASE,"A process of increasing the beta-glucosidase activity associated with Gaucher disease is provided. The process includes exposing the glucosidase to a chemical chaperone that has a high ratio of chaperone activity to inhibitor activity against glucosidase. Exemplary and preferred chaperones are a sterically bulky deoxynojirimycin compound and a sterically bulky 2,5-dideoxy-2,5-imino-D-mannitol compound. A process of stabilizing beta-glucosidase is also provided.",SCRIPPS RESEARCH INST;;KELLY JEFFREY W;;SAWKAR ANU R;;BEUTLER ERNEST;;WONG CHI-HEUY;;BALCH WILLIAM E,KELLY JEFFREY W;;SAWKAR ANU R;;BEUTLER ERNEST;;WONG CHI-HEUY;;BALCH WILLIAM E,,https://lens.org/182-311-704-950-038,Search Report,yes,3,0,4,4,0,A61K31/40;;A61K31/445;;C07D295/03;;C07D207/16;;C07D295/088;;C07D491/04,A61K31/40;;A61K31/445;;C07D207/16;;C07D295/02;;C07D295/03;;C07D295/088;;C07D491/04,,0,0,,,,PENDING
12,AU,A,AU 1994/079728 A,194-170-981-234-928,1995-05-22,1995,AU 1994/079728 A,1994-10-06,US 14387393 A;;US 17367793 A;;US 9411462 W,1993-10-27,Adjustable vehicle-carrying frame for insertion into differently-sized containers,,G & G INTELLECTUAL PROPERTIES INC,GEARIN PETER;;HALPIN TERENCE;;PILEGGI JAMES D;;BROWNE MICHAEL P J;;BEUTLER WILLIAM C,,https://lens.org/194-170-981-234-928,Patent Application,no,0,0,10,10,0,B60P3/07;;B60P3/08;;B61D3/18;;B61D3/20;;B65D88/005;;B65D88/022;;B65D88/121;;B65D88/123;;B65D2585/6867;;B65G2201/0294;;A47F5/00;;B65D88/121;;B65D88/022;;B65D88/123;;B65G2201/0294;;B60P3/08;;B65D88/005;;B60P3/07;;B61D3/20;;B61D3/18;;B65D2585/6867,B60P3/07;;B60P3/08;;B61D3/18;;B61D3/20;;B65D85/68;;B65D88/00;;B65D88/02;;B65D88/12;;B65D90/00,,0,0,,,,EXPIRED
13,AU,B2,AU 675182 B2,049-083-108-278-464,1997-01-23,1997,AU 1994/079728 A,1994-10-06,US 14387393 A;;US 17367793 A;;US 9411462 W,1993-10-27,Adjustable vehicle-carrying frame for insertion into differently-sized containers,,G & G INTELLECTUAL PROPERTIES,GEARIN PETER;;HALPIN TERENCE;;PILEGGI JAMES D;;BROWNE MICHAEL P J;;BEUTLER WILLIAM C,,https://lens.org/049-083-108-278-464,Granted Patent,no,3,0,10,10,0,B60P3/07;;B60P3/08;;B61D3/18;;B61D3/20;;B65D88/005;;B65D88/022;;B65D88/121;;B65D88/123;;B65D2585/6867;;B65G2201/0294;;A47F5/00;;B65D88/121;;B65D88/022;;B65D88/123;;B65G2201/0294;;B60P3/08;;B65D88/005;;B60P3/07;;B61D3/20;;B61D3/18;;B65D2585/6867,B60P3/07;;B60P3/08;;B61D3/18;;B61D3/20;;B65D85/68;;B65D88/00;;B65D88/02;;B65D88/12;;B65D90/00,,0,0,,,,EXPIRED
14,AU,A1,AU 2003/284886 A1,085-282-550-530-180,2004-05-13,2004,AU 2003/284886 A,2003-10-21,US 42047302 P;;US 0333670 W,2002-10-21,CHEMICAL CHAPERONES AND THEIR EFFECT UPON THE CELLULAR ACTIVITY OF Beta-GLUCOSIDASE,,SAWKAR ANU R;;BEUTLER ERNEST;;WONG CHI HEUY;;BALCH WILLIAM E;;SCRIPPS RESEARCH INST;;KELLY JEFFREY W,BEUTLER ERNEST;;WONG CHI-HEUY;;BALCH WILLIAM E;;KELLY JEFFREY W;;SAWKAR ANU R,,https://lens.org/085-282-550-530-180,Patent Application,no,0,0,4,4,0,A61K31/40;;A61K31/445;;C07D295/03;;C07D207/16;;C07D295/088;;C07D491/04,A61K31/40;;A61K31/445;;C07D207/16;;C07D295/02;;C07D295/03;;C07D295/088;;C07D491/04,,0,0,,,,DISCONTINUED
15,EP,A4,EP 0727950 A4,133-378-713-955-024,1997-04-09,1997,EP 94930682 A,1994-10-06,US 9411462 W;;US 14387393 A;;US 17367793 A,1993-10-27,ADJUSTABLE VEHICLE-CARRYING FRAME FOR INSERTION INTO DIFFERENTLY-SIZED CONTAINERS,,G & G INTELLECTUAL PROPERTIES,GEARIN PETER;;HALPIN TERENCE;;PILEGGI JAMES D;;BROWNE MICHAEL P J;;BEUTLER WILLIAM C,,https://lens.org/133-378-713-955-024,Search Report,no,1,0,10,10,0,B60P3/07;;B60P3/08;;B61D3/18;;B61D3/20;;B65D88/005;;B65D88/022;;B65D88/121;;B65D88/123;;B65D2585/6867;;B65G2201/0294;;A47F5/00;;B65D88/121;;B65D88/022;;B65D88/123;;B65G2201/0294;;B60P3/08;;B65D88/005;;B60P3/07;;B61D3/20;;B61D3/18;;B65D2585/6867,B60P3/07;;B60P3/08;;B61D3/18;;B61D3/20;;B65D85/68;;B65D88/00;;B65D88/02;;B65D88/12;;B65D90/00,,0,0,,,,DISCONTINUED
16,AU,A8,AU 2003/284886 A8,052-016-239-356-811,2004-05-13,2004,AU 2003/284886 A,2003-10-21,US 42047302 P;;US 0333670 W,2002-10-21,Chemical chaperones and their effect upon the cellular activity of beta-glucosidase,,SCRIPPS RESEARCH INST;;BALCH WILLIAM E;;WONG CHI HEUY;;BEUTLER ERNEST;;KELLY JEFFREY W;;SAWKAR ANU R,BALCH WILLIAM E;;SAWKAR ANU R;;BEUTLER ERNEST;;KELLY JEFFREY W;;WONG CHI-HEUY,,https://lens.org/052-016-239-356-811,Patent Application,no,0,0,4,4,0,A61K31/40;;A61K31/445;;C07D295/03;;C07D207/16;;C07D295/088;;C07D491/04,A61K31/40;;A61K31/445;;C07D207/16;;C07D295/02;;C07D295/03;;C07D295/088;;C07D491/04,,0,0,,,,DISCONTINUED
17,US,A,US 5445278 A,152-300-635-636-368,1995-08-29,1995,US 17367793 A,1993-12-22,US 17367793 A;;US 14387393 A;;US 87128892 A;;US 72089391 A;;US 50047690 A;;US 26150488 A;;US 94368886 A,1986-12-18,Adjustable vehicle-carrying frame for insertion into differently-sized containers,"An adjustable frame for carrying vehicles between elongate upright sides preferably includes a length-adjusting mechanism for expanding the length of the frame to fit transport containers of different sizes, a friction-reducing mechanism for smoother, safer and faster lengthwise adjustment of the respective frame sections, and a door-protecting mechanism including not only the length-adjusting mechanism but also shock-absorbing bumper assemblies for protecting the container door, the frame and the vehicles on the frame through a reduction in the peak level of shock forces generated during collisions between the container door and the frame. Preferably, the adjustable frame has only two sections for faster locking and is configured to flexibly accommodate different vehicle lengths, including by support of a pair of vehicle wheels in a center position on the frame.",G & G INTELLECTUAL PROPERTIES,GEARIN PETER;;HALPIN TERENCE;;PILEGGI JAMES D;;BROWNE MICHAEL P J;;BEUTLER WILLIAM C,G & G INTELLECTUAL PROPERTIES INC (1993-12-17),https://lens.org/152-300-635-636-368,Granted Patent,yes,14,23,10,10,0,B60P3/07;;B60P3/08;;B61D3/18;;B61D3/20;;B65D88/005;;B65D88/022;;B65D88/121;;B65D88/123;;B65D2585/6867;;B65G2201/0294;;A47F5/00;;B65D88/121;;B65D88/022;;B65D88/123;;B65G2201/0294;;B60P3/08;;B65D88/005;;B60P3/07;;B61D3/20;;B61D3/18;;B65D2585/6867,B60P3/07;;B60P3/08;;B61D3/18;;B61D3/20;;B65D85/68;;B65D88/00;;B65D88/02;;B65D88/12;;B65D90/00,211/13;;410/9;;410/16;;410/18;;414/400;;414/786,1,0,,,"Ace Controls, Inc., Catalog No. 48 10 91 (Published 1988).",EXPIRED
18,CA,A1,CA 2170634 A1,032-949-289-884-128,1995-05-04,1995,CA 2170634 A,1994-10-06,US 14387393 A;;US 17367793 A,1993-10-27,Adjustable Vehicle-Carrying Frame for Insertion Into Differently-Sized Containers,,G & G INTELLECTUAL PROPERTIES,GEARIN PETER;;HALPIN TERENCE;;PILEGGI JAMES D;;BROWN MICHAEL P J;;BEUTLER WILLIAM C,,https://lens.org/032-949-289-884-128,Patent Application,no,0,0,10,10,0,B60P3/07;;B60P3/08;;B61D3/18;;B61D3/20;;B65D88/005;;B65D88/022;;B65D88/121;;B65D88/123;;B65D2585/6867;;B65G2201/0294;;A47F5/00;;B65D88/121;;B65D88/022;;B65D88/123;;B65G2201/0294;;B60P3/08;;B65D88/005;;B60P3/07;;B61D3/20;;B61D3/18;;B65D2585/6867,B60P3/07;;B60P3/08;;B61D3/18;;B61D3/20;;B65D85/68;;B65D88/00;;B65D88/02;;B65D88/12;;B65D90/00,,0,0,,,,EXPIRED
19,WO,A2,WO 2004/037373 A2,134-065-192-893-639,2004-05-06,2004,US 0333670 W,2003-10-21,US 42047302 P,2002-10-21,CHEMICAL CHAPERONES AND THEIR EFFECT UPON THE CELLULAR ACTIVITY OF beta-GLUCOSIDASE,"A process of increasing the beta-glucosidase activity associated with Gaucher disease is provided. The process includes exposing the glucosidase to a chemical chaperone that has a high ratio of chaperone activity to inhibitor activity against glucosidase. Exemplary and preferred chaperones are a sterically bulky deoxynojirimycin compound and a sterically bulky 2,5-dideoxy-2,5-imino-D-mannitol compound. A process of stabilizing beta-glucosidase is also provided.",SCRIPPS RESEARCH INST;;KELLY JEFFREY W;;SAWKAR ANU R;;BEUTLER ERNEST;;WONG CHI-HEUY;;BALCH WILLIAM E,KELLY JEFFREY W;;SAWKAR ANU R;;BEUTLER ERNEST;;WONG CHI-HEUY;;BALCH WILLIAM E,,https://lens.org/134-065-192-893-639,Patent Application,yes,0,21,4,4,0,A61K31/40;;A61K31/445;;C07D295/03;;C07D207/16;;C07D295/088;;C07D491/04,A61K31/40;;A61K31/445;;C07D207/16;;C07D295/02;;C07D295/03;;C07D295/088;;C07D491/04,,0,0,,,,PENDING
20,EP,A1,EP 0727950 A1,175-506-511-482-625,1996-08-28,1996,EP 94930682 A,1994-10-06,US 9411462 W;;US 14387393 A;;US 17367793 A,1993-10-27,ADJUSTABLE VEHICLE-CARRYING FRAME FOR INSERTION INTO DIFFERENTLY-SIZED CONTAINERS,,G & G INTELLECTUAL PROPERTIES,GEARIN PETER;;HALPIN TERENCE;;PILEGGI JAMES D;;BROWNE MICHAEL P J;;BEUTLER WILLIAM C,,https://lens.org/175-506-511-482-625,Patent Application,yes,0,0,10,10,0,B60P3/07;;B60P3/08;;B61D3/18;;B61D3/20;;B65D88/005;;B65D88/022;;B65D88/121;;B65D88/123;;B65D2585/6867;;B65G2201/0294;;A47F5/00;;B65D88/121;;B65D88/022;;B65D88/123;;B65G2201/0294;;B60P3/08;;B65D88/005;;B60P3/07;;B61D3/20;;B61D3/18;;B65D2585/6867,B60P3/07;;B60P3/08;;B61D3/18;;B61D3/20;;B65D85/68;;B65D88/00;;B65D88/02;;B65D88/12;;B65D90/00,,0,0,,,,DISCONTINUED
21,US,B2,US 9676788 B2,095-839-993-570-155,2017-06-13,2017,US 201515116887 A,2015-02-05,US 201515116887 A;;US 201461936285 P;;US 201462018381 P;;US 2015/0014601 W,2014-02-05,Aza-epoxy-guaiane derivatives and treatment of cancer,"Disclosed is a compound of formula (I) or formula (II): (Formulas should be inserted here) wherein R 1 -R 6 are as defined herein. Also disclosed are a pharmaceutical composition comprising such a compound and a method of treating or preventing cancer in a mammal in need thereof, comprising administering to the mammal a compound of formula (I) or formula (II).",US HEALTH;;UNIV HAWAII,CHAIN WILLIAM J;;BEUTLER JOHN A;;FASH DAVID;;FIGG WILLIAM D;;LI ZHENWU;;PEER CODY JOHN;;RAMOS JOE WILLIAM;;SULZMAIER FLORIAN J,THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES (2017-01-06);;UNIVERSITY OF HAWAII (2017-01-06),https://lens.org/095-839-993-570-155,Granted Patent,yes,8,0,10,10,0,C07D493/08;;A61K31/352;;A61P3/00;;A61P31/00;;A61P35/00;;A61P9/00;;C07D493/08;;A61K9/0053;;A61K31/352;;A61K45/06,C07D493/08;;A61K9/00;;A61K31/352;;A61K45/06,,28,25,058-482-345-033-756;;002-567-009-774-230;;031-076-768-104-137;;053-140-499-975-031;;021-257-821-211-477;;090-867-930-655-852;;043-468-943-894-032;;049-206-013-162-853;;155-216-573-885-111;;087-691-862-225-230;;035-973-322-568-362;;033-313-295-307-397;;073-312-334-005-41X;;112-795-603-877-577;;006-640-135-802-451;;084-370-515-749-914;;031-262-538-370-842;;017-302-649-463-562;;020-377-730-105-409;;061-374-863-127-701;;047-044-601-804-208;;078-433-256-600-151;;068-224-534-415-447;;080-887-795-747-484;;001-245-878-390-695,10.1021/np200905u;;22280462;;pmc3311709;;21360817;;10.1002/cmdc.201000544;;10.1055/s-0030-1289521;;3409486;;10.1161/01.res.63.3.543;;pmc3093978;;21325107;;10.1152/ajpendo.00699.2010;;22564056;;10.1021/ol3007524;;pmc3390928;;10.1021/ja201921j;;21476574;;10.1002/anie.201000890;;20544903;;10.1021/ja102927n;;20496885;;22162365;;10.1002/asia.201100780;;21472928;;10.1002/anie.201007790;;19061394;;pmc2651161;;10.1021/ol802339w;;10.1016/j.ccr.2012.12.007;;pmc3574184;;23352416;;10.1371/journal.pone.0048032;;23144724;;pmc3481555;;10.1002/anie.201103128;;21780264;;10.1021/jo301145r;;22871030;;21413694;;10.1021/ol200499t;;10.1002/chem.201203467;;23292997;;10.1055/s-0031-1290090;;19882614;;10.1002/anie.200905032;;20669919;;pmc2927118;;10.1021/ol1015652;;22415793;;10.1002/asia.201101021;;pmc3338859;;10.1002/anie.201301247;;23589512;;10.1016/j.tetlet.2014.01.012;;20544902;;10.1002/anie.201000888,"Akee et al., “Chlorinated Englerins with Selective Inhibition of Renal Cancer Cell Growth” Journal of Natural Products 75(3) 459-463 (2012).;;Chan et al., “Chemical Synthesis and Biological Evaluation of the Englerin Analogues”, ChemMedChem, Wiley—VCH Verlag., 6 (3) 420-423 (Mar. 7, 2011).;;Chain et al., “Synthetic Strategies toward the Guaiane Sesquiterpene Englerin A” Synlett 2605-2608 (2011).;;Currie et al., “Heat-shock response is associated with enhanced postischemic ventricular recovery”, Cir. Res. 63, 395-397 (1988).;;European Patent Office, International Search Report in International Patent Application No. PCT/US2015/014601, 5 pages, Mar. 20, 2015.;;European Patent Office, Written Opinion of the International Searching Authority in International Patent Application No. PCT/US2015/014601, 6 pages, Mar. 20, 2015.;;European Patent Office, International Preliminary Report on Patentability in International Patent Application No. PCT/US2015/014601, 7 pages, Mar. 20, 2015.;;Kavanagh et al., “Restoring HSP70 deficiencies improves glucose tolerance in diabetic monkeys,” Am. J. Physiol. Endocrinol. Metab., 300 (5), E894-E901 (2011).;;Lee et al., “A Formal Synthesis of (−)-Englerin A by Relay Ring Closing Metathesis and Transannular Etherification” Organic Letters, 14(11) 2682-2685 (2012).;;Li et al., “A brief synthesis of (−)-englerin A,” J. Am. Chem. Soc., 133 (17), 6553-6556 (2011).;;Molawi et al., “Enantioselective Synthesis of (−)-Englerins A and B” Angew. Chem. Int. Ed.49 (20) 3517-3519 (2010).;;Nicolaou et al., “Total Synthesis of Englerin A” Journal of the American Chemical Society, American Chemical Society, 132 (23) 8219-8222 (May 24, 2010).;;Pouwer et al. “Chemical Synthesis of the Englerins” Chem. Asian J.7, 22-35 (2012).;;Radtke, et al., “Total Synthesis and Biological Evaluation of (−)-Englerin&emsp 14;A and B: Synthesis of Analogues with Improved Activity Profile”, Angewandte Chemie International Edition, 50 (17) 3998-4002 (Apr. 18, 2011).;;Ratnayake et al., “Englerin A, a Selective Inhibitor of Renal Cancer Cell Growth, from Phyllanthus engleri” Organic Letters, American Chemical Society, US, 11 (1) 57-60 (2008; Jan. 1, 2009).;;Sourbier et al., “Englerin A Stimulates PKC0 to Inhibit Insulin Signaling and to Simultaneously Activate HSF1: Pharmacologically Induced Synthetic Lethality”, Cancer Cell 23 (228) 2013.;;Sulzmaier et al., “Englerin A selectively induces necrosis in human renal cancer cells.” PLoS ONE, 7 e48032 (2012).;;Szostak et al., “Concise Syntheses of Strychnine and Englerin A: the Power of Reductive Cyclizations Triggered by Samarium Iodide” Angewandte Chemie, International Edition 50(34) 7737-7739 (2011).;;Takahashi et al., “Stereocontrolled Total Synthesis of (−)-Englerin A” Journal of Organic Chemistry, 77(17) 7364-7370 (2012).;;Ushakov, et al. “Total Synthesis and Biological Evaluation of (−)-9-Deoxy-englerin A ” Org. Lett. 13, 2090-2093 (2011).;;Wang et al., “Collective Total Synthesis of Englerin A and B, Orientalol E and F, and Oxyphyllol: Application of the Organocatalytic [4+3] Cycloaddition Reaction” Chemistry—A European Journal, 19(7) 2539-2547 (2013).;;Wang et al., “Concise formal synthesis of (+)-englerin A and total synthesis of (−)-orientalol F: establishment of the stereochemistry of the organocatalytic [4+3]-cycloaddition reaction” Synlett, 23(2) 263-266 (2012).;;Willot et al., “Totasl Synthesis and Absolute Configuration of the Guaiane Sesquiterpene Englerin A” Angew. Chem. Int. Ed. 48 (48) 9105-9108 (2009).;;Xu et al., “Enantioselective Formal Synthesis of (−)-Englerin A via a Rh-Catalyzed [4+3] Cycloaddition Reaction” Org. Lett. 12, 3708-3711 (2010).;;Xu et al., “Formal Synthesis of (−)-Englerin A and Cytotoxicity Studies of Truncated Englerins” Chemistry—An Asian Journal, 7(5) 1052-1060 (2012).;;Zahel et al., “A Short Enantioselective Total Synthesis of (−)-Englerin A” Angewandte Chemie, International Edition, 52(20) 5390-5392 (2013).;;Zhang et al., “Total synthesis of (−)-Englerin A” Tetrahedron Letters 55(7), 1339-1341 (2014).;;Zhou at al., “Asymmetric, Protecting-Group-Free Total Synthesis of (−)-Englerin A” Angew. Chem. Int. Ed. 49, 3513-3516 (2010).",ACTIVE
22,EP,B1,EP 3102581 B1,177-392-153-600-037,2018-05-02,2018,EP 15705869 A,2015-02-05,US 201461936285 P;;US 201462018381 P;;US 2015/0014601 W,2014-02-05,AZA-EPOXY-GUAIANE DERIVATIVES AND TREATMENT OF CANCER,,US HEALTH;;UNIV HAWAII,CHAIN WILLIAM J;;BEUTLER JOHN A;;FASH DAVID;;FIGG WILLIAM D;;LI ZHENWU;;PEER CODY JOHN;;RAMOS JOE WILLIAM;;SULZMAIER FLORIAN J,"UNIVERSITY OF HAWAII (2017-12-20);;THE UNITED STATES OF AMERICA, AS REPRESENTED BY TH (2017-12-20)",https://lens.org/177-392-153-600-037,Granted Patent,yes,1,0,10,10,0,C07D493/08;;A61K31/352;;A61P3/00;;A61P31/00;;A61P35/00;;A61P9/00;;C07D493/08;;A61K9/0053;;A61K31/352;;A61K45/06,C07D493/08;;A61K31/352;;A61P3/00;;A61P9/00;;A61P31/00;;A61P35/00,,2,0,,,"LEA RADTKE ET AL: ""Total Synthesis and Biological Evaluation of (-)-Englerin&emsp14;A and B: Synthesis of Analogues with Improved Activity Profile"", ANGEWANDTE CHEMIE INTERNATIONAL EDITION, vol. 50, no. 17, 18 April 2011 (2011-04-18), pages 3998-4002, XP055020791, ISSN: 1433-7851, DOI: 10.1002/anie.201007790;;DR KOK PING CHAN ET AL: ""Chemical Synthesis and Biological Evaluation of the Englerin Analogues"", CHEMMEDCHEM, WILEY - VCH VERLAG., WEINHEIM, DE, vol. 6, no. 3, 7 March 2011 (2011-03-07), pages 420-423, XP009146097, ISSN: 1860-7179, DOI: 10.1002/CMDC.201000544 [retrieved on 2011-01-18]",ACTIVE
23,US,A1,US 2016/0347764 A1,033-305-556-601-384,2016-12-01,2016,US 201515116887 A,2015-02-05,US 201515116887 A;;US 201461936285 P;;US 201462018381 P;;US 2015/0014601 W,2014-02-05,AZA-EPOXY-GUAIANE DERIVATIVES AND TREATMENT OF CANCER,"Disclosed is a compound of formula (I) or formula (II): (Formulas should be inserted here) wherein R 1 -R 6 are as defined herein. Also disclosed are a pharmaceutical composition comprising such a compound and a method of treating or preventing cancer in a mammal in need thereof, comprising administering to the mammal a compound of formula (I) or formula (II).",US HEALTH;;UNIV HAWAII,CHAIN WILLIAM J;;BEUTLER JOHN A;;FASH DAVID;;FIGG WILLIAM D;;LI ZHENWU;;PEER CODY JOHN;;RAMOS JOE WILLIAM;;SULZMAIER FLORIAN J,THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES (2017-01-06);;UNIVERSITY OF HAWAII (2017-01-06),https://lens.org/033-305-556-601-384,Patent Application,yes,0,1,10,10,0,C07D493/08;;A61K31/352;;A61P3/00;;A61P31/00;;A61P35/00;;A61P9/00;;C07D493/08;;A61K9/0053;;A61K31/352;;A61K45/06,C07D493/08;;A61K9/00;;A61K31/352;;A61K45/06,,0,0,,,,ACTIVE
24,AU,B2,AU 2015/214189 B2,056-425-748-356-134,2018-12-13,2018,AU 2015/214189 A,2015-02-05,US 201462018381 P;;US 201461936285 P;;US 2015/0014601 W,2014-02-05,Aza-epoxy-guaiane derivatives and treatment of cancer,Disclosed is a compound of formula (I) or formula (II): (Formulas should be inserted here) wherein R,THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY;;UNIV HAWAII,CHAIN WILLIAM J;;BEUTLER JOHN A;;FASH DAVID;;FIGG WILLIAM D;;LI ZHENWU;;PEER CODY JOHN;;RAMOS JOE WILLIAM;;SULZMAIER FLORIAN J,,https://lens.org/056-425-748-356-134,Granted Patent,no,1,0,10,10,0,C07D493/08;;A61K31/352;;A61P3/00;;A61P31/00;;A61P35/00;;A61P9/00;;C07D493/08;;A61K9/0053;;A61K31/352;;A61K45/06,C07D493/08;;A61K31/352;;A61P3/00;;A61P9/00;;A61P31/00;;A61P35/00,,0,0,,,,ACTIVE
25,ES,T3,ES 2682368 T3,062-792-866-143-852,2018-09-20,2018,ES 15705869 T,2015-02-05,US 201461936285 P;;US 201462018381 P;;US 2015/0014601 W,2014-02-05,Derivados de aza-epoxi-guayano y tratamiento del cáncer,"Compuesto de fórmula (I) o fórmula (II):**Fórmula** o un epímero del mismo, en las que R1 es isopropilo o isopropilenilo, R2 y R3 son independientemente alquilo C1-C6, R4 es arilo C6-C10 o cicloalquilo C3-C8, en el que el arilo está opcionalmente sustituido con alquilo C1-C6, hidroxialquilo C1-C6, alcoxilo C1-C6, halo o nitro, R5 es hidrógeno o alquilo C1-C6, y R6 es alquilo C1-C6, hidroxialquilo C1-C6 o fluoroalquilo C1-C6.",US HEALTH;;UNIV HAWAII,CHAIN WILLIAM J;;BEUTLER JOHN A;;FASH DAVID;;FIGG WILLIAM D;;LI ZHENWU;;PEER CODY JOHN;;RAMOS JOE WILLIAM;;SULZMAIER FLORIAN J,,https://lens.org/062-792-866-143-852,Granted Patent,no,0,0,10,10,0,C07D493/08;;A61K31/352;;A61P3/00;;A61P31/00;;A61P35/00;;A61P9/00;;C07D493/08;;A61K9/0053;;A61K31/352;;A61K45/06,C07D493/08;;A61K31/352;;A61P3/00;;A61P9/00;;A61P31/00;;A61P35/00,,0,0,,,,ACTIVE
26,WO,A1,WO 2015/120140 A1,064-216-868-331-221,2015-08-13,2015,US 2015/0014601 W,2015-02-05,US 201461936285 P;;US 201462018381 P,2014-02-05,AZA-EPOXY-GUAIANE DERIVATIVES AND TREATMENT OF CANCER,"Disclosed is a compound of formula (I) or formula (II): (Formulas should be inserted here) wherein R 1 -R 6 are as defined herein. Also disclosed are a pharmaceutical composition comprising such a compound and a method of treating or preventing cancer in a mammal in need thereof, comprising administering to the mammal a compound of formula (I) or formula (II).",US HEALTH;;UNIV HAWAII,CHAIN WILLIAM J;;BEUTLER JOHN A;;FASH DAVID;;FIGG WILLIAM D;;LI ZHENWU;;PEER CODY JOHN;;RAMOS JOE WILLIAM;;SULZMAIER FLORIAN J,,https://lens.org/064-216-868-331-221,Patent Application,yes,6,1,10,10,0,C07D493/08;;A61K31/352;;A61P3/00;;A61P31/00;;A61P35/00;;A61P9/00;;C07D493/08;;A61K9/0053;;A61K31/352;;A61K45/06,C07D493/08;;A61K31/352;;A61P3/00;;A61P9/00;;A61P31/00;;A61P35/00,,16,9,002-567-009-774-230;;043-468-943-894-032;;021-257-821-211-477;;018-344-144-106-967;;019-817-021-691-872;;065-010-469-101-288;;038-751-055-075-55X;;041-810-386-582-21X;;003-863-275-065-114,21360817;;10.1002/cmdc.201000544;;10.1021/ja201921j;;21476574;;pmc3093978;;21325107;;10.1152/ajpendo.00699.2010;;10.1002/1097-0142(197510)36:4<1258::aid-cncr2820360411>3.0.co;2-6;;1100221;;10.1146/annurev.bb.09.060180.002343;;6994593;;10.1016/s0040-4020(01)91944-1;;10.1021/ol047810q;;15673246;;12841781;;10.1021/ol034883l;;10.1246/cl.1989.1283,"LEA RADTKE ET AL: ""Total Synthesis and Biological Evaluation of (-)-Englerin A and B: Synthesis of Analogues with Improved Activity Profile"", ANGEWANDTE CHEMIE INTERNATIONAL EDITION, vol. 50, no. 17, 18 April 2011 (2011-04-18), pages 3998 - 4002, XP055020791, ISSN: 1433-7851, DOI: 10.1002/anie.201007790;;DR KOK PING CHAN ET AL: ""Chemical Synthesis and Biological Evaluation of the Englerin Analogues"", CHEMMEDCHEM, WILEY - VCH VERLAG., WEINHEIM, DE, vol. 6, no. 3, 7 March 2011 (2011-03-07), pages 420 - 423, XP009146097, ISSN: 1860-7179, [retrieved on 20110118], DOI: 10.1002/CMDC.201000544;;Z. LI ET AL., J. AM. CHEM. SOC., vol. 133, no. 17, 2011, pages 6553 - 6556;;KAVANAGH, K. ET AL., AM. J PHYSIOL ENDOCRINOL METAB., vol. 300, 2011, pages E894 - E901;;CURIE ET AL.: ""Heat-shock response is associated with enhanced postischemic ventricular recovery"", CIR. RES., vol. 63, 1988, pages 395 - 397;;PHYSICIANS' DESK REFERENCE, 2004;;WASSERMAN ET AL., CANCER, vol. 36, 1975, pages 1258 - 1268;;""Physicians' Desk Reference"", 2004, THOMSON PDR;;""Pharmaceutics and Pharmacy Practice"", 1982, J.B. LIPPINCOTT COMPANY, pages: 238 - 250;;""ASHP Handbook on Injectable Drugs"", 1986, TOISSEL, pages: 622 - 630;;""Remington's Pharmaceutical Science"", 1985, MACK PUBLISHING COMPANY;;SZOKA ET AL., ANN. REV. BIOPHYS. BIOENG., vol. 9, 1980, pages 467;;S.K. MUKERJI ET AL., TETRAHEDRON, vol. 39, 1983, pages 2231 - 2235;;J.D. WINKLER ET AL., ORG. LETT., vol. 7, 2005, pages 387 - 389;;D.E. CHAVEZ ET AL., ORG. LETT., vol. 5, no. 14, 2003, pages 2563 - 2565;;S. TAKANO ET AL., CHEM. LETT., 1989, pages 1283 - 1284",PENDING
27,CA,C,CA 2938971 C,024-487-772-820-817,2022-03-15,2022,CA 2938971 A,2015-02-05,US 201461936285 P;;US 201462018381 P;;US 2015/0014601 W,2014-02-05,AZA-EPOXY-GUAIANE DERIVATIVES AND TREATMENT OF CANCER,"Disclosed is a compound of formula (I) or formula (II): (Formulas should be inserted here) wherein R1-R6 are as defined herein. Also disclosed are a pharmaceutical composition comprising such a compound and a method of treating or preventing cancer in a mammal in need thereof, comprising administering to the mammal a compound of formula (I) or formula (II).",US HEALTH;;UNIV HAWAII,CHAIN WILLIAM J;;BEUTLER JOHN A;;FASH DAVID;;FIGG WILLIAM D;;LI ZHENWU;;PEER CODY JOHN;;RAMOS JOE WILLIAM;;SULZMAIER FLORIAN J,,https://lens.org/024-487-772-820-817,Granted Patent,no,0,0,10,10,0,C07D493/08;;A61K31/352;;A61P3/00;;A61P31/00;;A61P35/00;;A61P9/00;;C07D493/08;;A61K9/0053;;A61K31/352;;A61K45/06,C07D493/08;;A61K31/352;;A61P3/00;;A61P9/00;;A61P31/00;;A61P35/00,,0,0,,,,PENDING
28,CA,A1,CA 2938971 A1,052-813-154-394-220,2015-08-13,2015,CA 2938971 A,2015-02-05,US 201461936285 P;;US 201462018381 P;;US 2015/0014601 W,2014-02-05,AZA-EPOXY-GUAIANE DERIVATIVES AND TREATMENT OF CANCER,"Disclosed is a compound of formula (I) or formula (II): (Formulas should be inserted here) wherein R1-R6 are as defined herein. Also disclosed are a pharmaceutical composition comprising such a compound and a method of treating or preventing cancer in a mammal in need thereof, comprising administering to the mammal a compound of formula (I) or formula (II).",US HEALTH;;UNIV HAWAII,CHAIN WILLIAM J;;BEUTLER JOHN A;;FASH DAVID;;FIGG WILLIAM D;;LI ZHENWU;;PEER CODY JOHN;;RAMOS JOE WILLIAM;;SULZMAIER FLORIAN J,,https://lens.org/052-813-154-394-220,Patent Application,no,0,0,10,10,0,C07D493/08;;A61K31/352;;A61P3/00;;A61P31/00;;A61P35/00;;A61P9/00;;C07D493/08;;A61K9/0053;;A61K31/352;;A61K45/06,C07D493/08;;A61K31/352;;A61P3/00;;A61P9/00;;A61P31/00;;A61P35/00,,0,0,,,,PENDING
29,AU,A1,AU 2015/214189 A1,151-455-017-797-48X,2016-08-18,2016,AU 2015/214189 A,2015-02-05,US 201462018381 P;;US 201461936285 P;;US 2015/0014601 W,2014-02-05,Aza-epoxy-guaiane derivatives and treatment of cancer,Disclosed is a compound of formula (I) or formula (II): (Formulas should be inserted here) wherein R,US HEALTH;;UNIV HAWAII,CHAIN WILLIAM J;;BEUTLER JOHN A;;FASH DAVID;;FIGG WILLIAM D;;LI ZHENWU;;PEER CODY JOHN;;RAMOS JOE WILLIAM;;SULZMAIER FLORIAN J,,https://lens.org/151-455-017-797-48X,Patent Application,no,0,0,10,10,0,C07D493/08;;A61K31/352;;A61P3/00;;A61P31/00;;A61P35/00;;A61P9/00;;C07D493/08;;A61K9/0053;;A61K31/352;;A61K45/06,C07D493/08;;A61K31/352;;A61P3/00;;A61P9/00;;A61P31/00;;A61P35/00,,0,0,,,,ACTIVE
30,EP,A1,EP 3102581 A1,093-884-578-975-104,2016-12-14,2016,EP 15705869 A,2015-02-05,US 201461936285 P;;US 201462018381 P;;US 2015/0014601 W,2014-02-05,AZA-EPOXY-GUAIANE DERIVATIVES AND TREATMENT OF CANCER,,US HEALTH;;UNIV HAWAII,CHAIN WILLIAM J;;BEUTLER JOHN A;;FASH DAVID;;FIGG WILLIAM D;;LI ZHENWU;;PEER CODY JOHN;;RAMOS JOE WILLIAM;;SULZMAIER FLORIAN J,"UNIVERSITY OF HAWAII (2017-12-20);;THE UNITED STATES OF AMERICA, AS REPRESENTED BY TH (2017-12-20)",https://lens.org/093-884-578-975-104,Patent Application,yes,0,0,10,10,0,C07D493/08;;A61K31/352;;A61P3/00;;A61P31/00;;A61P35/00;;A61P9/00;;C07D493/08;;A61K9/0053;;A61K31/352;;A61K45/06,C07D493/08;;A61K31/352;;A61P3/00;;A61P9/00;;A61P31/00;;A61P35/00,,0,0,,,,ACTIVE
31,US,A,US 5086045 A,165-372-347-464-252,1992-02-04,1992,US 57206290 A,1990-08-24,US 57206290 A;;US 32364889 A,1989-03-15,Antitumor antibiotic,An antitumor antibiotic designated BMY-41339 is produced by fermentation of certain strains of Actinomadura verrucosospora. BMY-41339 exhibits antimicrobial activity and also inhibits the growth of tumors in experimental animals.,BRISTOL MYERS SQUIBB CO,GOLIK JERZY;;BEUTLER JOHN;;CLARK PAT;;ROSS JOHN;;ROACH JOHN;;MUSCHIK GARY;;LEBHERZ III WILLIAM B,,https://lens.org/165-372-347-464-252,Granted Patent,yes,5,2,1,8,0,C07H15/203;;C12P19/44;;C12R2001/03;;C12N1/205;;C07H15/203;;C12P19/44;;C12N1/205;;C12R2001/03,C07H15/203;;C12P19/44,514/61;;514/25;;536/6.5;;536/16.8;;536/17.2;;536/17.5;;536/17.6;;536/17.9;;536/18.1,2,0,,,"J. Antibiotics, 38 (11):1605 1609, (1985); J. Am. Chem. Soc., 109:3462 3464, (1987), J. Am. Chem. Soc., 109:3466 3468, (1987).;;Program and Abstracts of 26th Interscience Conference on Antimicrobial Agents and Chemotherapy, Sep. 1986, Abstract 227.",EXPIRED
32,US,A,US 5028536 A,149-380-312-106-076,1991-07-02,1991,US 32364889 A,1989-03-15,US 32364889 A,1989-03-15,Antitumor antibiotic BMY-41339,An antitumor antibiotic designated BMY-41339 is produced by fermentation of certain strains of Actinomadura verrucosospora. BMY-41339 exhibits antimicrobial activity and also inhibits the growth of tumors in experimental animals.,BRISTOL MYERS SQUIBB CO,GOLIK JERZY;;BEUTLER JOHN;;CLARK PAT;;ROSS JOHN;;ROACH JOHN;;MUSCHIK GARY;;LEBHERZ III WILLIAM B,BRISTOL-MYERS SQUIBB COMPANY (1989-11-07);;UNITED STATES OF AMERICA THE AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (1990-03-06),https://lens.org/149-380-312-106-076,Granted Patent,yes,4,11,7,8,0,C07H15/203;;C12P19/44;;A61P31/04;;A61P35/00;;A61P35/02;;C12R2001/03;;C12N1/205;;C07H15/203;;C12P19/44;;C12N1/205;;C12R2001/03,C12P19/56;;A61K31/70;;A61K31/7028;;A61K31/7034;;A61P31/04;;A61P35/00;;A61P35/02;;C07H15/203;;C12P19/44;;C12R1/03,435/101;;435/169;;435/128,3,1,027-776-016-150-037,10.1021/ja00245a049,"J. Antibiotics 38 (11):1605 1609 (1985); J. Am. Chem. Soc. 109:3462 3464 (1987).;;J. Am. Chem. Soc. 109:3462 3464 (1987).;;Program and Abstracts of 26th Interscience Conference on Antimicrobiol Agents and Chemotherapy, Sep. 1986, Abstract 227.",EXPIRED
33,WO,A1,WO 2019/010298 A1,155-080-325-518-363,2019-01-10,2019,US 2018/0040910 W,2018-07-05,US 201762529063 P,2017-07-06,ENGLERIN DERIVATIVES FOR TREATMENT OF CANCER,"Disclosed is a compound of formula (I) in which a, R 1 - R 5 and X 1 are as described herein. Also disclosed are a pharmaceutical composition containing the compound and a method of using the compound for treating cancer, such as renal cancer.",US HEALTH;;FUNDACIO INSTITUT CATALA DINVESTIGACIO QUIM;;UNIV DELAWARE;;UNIV LEEDS INNOVATIONS LTD;;UNIV ROVIRA I VIRGILI;;BEUTLER JOHN A;;ECHAVARREN ANTONIO;;CHAIN WILLIAM;;BEECH DAVID;;WU ZHENHUA;;SUPPO JEAN SIMON;;BRAVO FERNANDO;;RUBAIY HUSSEIN,BEUTLER JOHN;;ECHAVARREN ANTONIO;;CHAIN WILLIAM;;BEECH DAVID;;WU ZHENHUA;;SUPPO JEAN-SIMON;;BRAVO FERNANDO;;RUBAIY HUSSEIN,,https://lens.org/155-080-325-518-363,Patent Application,yes,9,0,11,11,0,C07D493/08;;A61P35/00;;C07D493/08;;C07D495/08;;C07D471/08,A61K31/35;;C07D493/08;;A61P35/00,,25,14,003-896-755-951-896;;063-719-352-867-752;;049-206-013-162-853;;155-216-573-885-111;;058-482-345-033-756;;078-433-256-600-151;;073-312-334-005-41X;;088-303-716-893-811;;014-391-185-229-644;;019-817-021-691-872;;060-811-994-934-606;;124-141-343-853-394;;153-099-981-949-441;;079-770-028-201-89X,pmc4862412;;10.1016/j.bmcl.2016.04.016;;27107948;;27005578;;10.1002/cmdc.201600040;;pmc4926265;;10.1002/anie.201000890;;20544903;;10.1021/ja102927n;;20496885;;10.1021/np200905u;;22280462;;pmc3311709;;22415793;;10.1002/asia.201101021;;pmc3338859;;10.1016/j.ccr.2012.12.007;;pmc3574184;;23352416;;pmc7116557;;25707820;;10.1002/anie.201411511;;29209034;;10.1038/s41598-017-17303-3;;pmc5717101;;10.1146/annurev.bb.09.060180.002343;;6994593;;18465867;;10.1021/ol800480d;;10.1021/jo801365z;;18698826;;10.1002/ange.201000890;;18759485;;10.1021/jo8014769,"D. M. FASH ET. AL.: ""Synthesis of a stable and orally bioavailable englerin analogue"", BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS, vol. 26, 8 April 2016 (2016-04-08), pages 2641 - 2644, XP002784084, DOI: 10.1016/j.bcml.2016.04.016;;L. LOPEZ-SUAREZ ET. AL.: ""Synthesis and Biologivcal Evaluation of New (-)-Englerin Analogues."", CHEMMEDCHEM, vol. 11, 23 March 2016 (2016-03-23), pages 1003 - 1007, XP002784085, DOI: 10.1002/cmdc.201600040;;RATANYAKE ET AL., ORGANIC LETTERS, vol. 11, 2008, pages 1,57 - 60;;RADTKE ET AL., ANGEW. CHEM. INT. ED., vol. 50, 2011, pages 3998;;ANGEW. CHEM. INT. ED., vol. 49, pages 3517 - 3519;;NICOLAOU ET AL., J. AM. CHEM. SOC., vol. 132, 2010, pages 8219 - 8222;;AKEE ET AL., J. NAT. PROD., vol. 75, 2012, pages 459 - 463;;XU ET AL., CHEM. ASIAN J., vol. 7, 2012, pages 1052 - 1060;;CHAN ET AL., CHEM. MED. CHEM., vol. 6, no. 3, 2011, pages 420 - 423;;SOURBIER ET AL., CANCER CELL, vol. 23, no. 2, 2013, pages 228 - 337;;AKBULUT ET AL., ANGEW. CHEM. INT. ED., vol. 54, 2015, pages 3787 - 3791;;MURAKI ET AL., SCIENTIFIC REPORTS, vol. 7, 2017, pages 16988;;CARSON ET AL., PLOS ONE, vol. 10, no. 6, 2015, pages 1 - 21;;""Remington's Pharmaceutical Sciences"", 1990, MACK PUBLISHING COMPANY, pages: 1445;;JOURNAL OF PHARMACEUTICAL SCIENCE, vol. 66, 1977, pages 2 - 19;;""Pharmaceutics and Pharmacy Practice"", 1982, J. B. LIPPINCOTT CO., pages: 238 - 250;;""ASHP Handbook on Injectable Drugs"", 1986, TOISSEL, pages: 622 - 630;;SZOKA ET AL., ANN. REV. BIOPHYS. BIOENG., vol. 9, 1980, pages 467;;""Goodman And Gilman's: The Pharmacological Bases of Therapeutics"", 1990, PERGAMON PRESS;;""Remington's Pharmaceutical Sciences"", 1990, MACK PUBLISHING CO.;;""Harrison's Principles of Internal Medicine"", 2001, pages: 491 762;;NAKATSUJI ET AL., ORG. LETT., vol. 10, 2008, pages 2131 - 2134;;RIOU ET AL., J. ORG. CHEM., vol. 73, 2008, pages 7436 - 7439;;MOLAWI ET AL., ANGEW. CHEM. INT. ED., vol. 122, 2010, pages 3595 - 3597;;AMIJS ET AL., J. ORG. CHEM., vol. 73, 2008, pages 7721 - 7730",PENDING
34,EP,A2,EP 0387860 A2,047-680-060-892-272,1990-09-19,1990,EP 90104853 A,1990-03-14,US 32364889 A,1989-03-15,Antitumor antibiotic BMY-41339.,A novel antitumor antibiotic of formula (I) designated BMY-41339 is produced by fermentation of certain strains of Actinomadura verrucosospora. BMY-41339 exhibits antimicrobial activity and also inhibits the growth of tumors in experimental animals.,BRISTOL MYERS SQUIBB CO;;US HEALTH,GOLIK JERZY;;BEUTLER JOHN DR;;CLARK PAT;;ROSS JOHN;;ROACH JOHN;;MUSCHIK GARY;;LEBHERZ WILLIAM B III,,https://lens.org/047-680-060-892-272,Patent Application,yes,0,0,7,8,0,C07H15/203;;C12P19/44;;A61P31/04;;A61P35/00;;A61P35/02;;C12R2001/03;;C12N1/205;;C07H15/203;;C12P19/44;;C12N1/205;;C12R2001/03,C12P19/56;;A61K31/70;;A61K31/7028;;A61K31/7034;;A61P31/04;;A61P35/00;;A61P35/02;;C07H15/203;;C12P19/44;;C12R1/03,,0,0,,,,DISCONTINUED
35,ES,T3,ES 2914325 T3,149-899-709-325-614,2022-06-09,2022,ES 18745789 T,2018-07-05,US 201762529063 P;;US 2018/0040910 W,2017-07-06,Derivados de englerina para el tratamiento del cáncer,"Un compuesto de fórmula (I) **(Ver fórmula)** en donde ""a"" representa un enlace sencillo o enlace doble; R1 es cicloalquilo C3-C6, heterocicloalquilo, arilo o heteroarilo, cada uno de los anteriores está opcionalmente sustituido; R2 se selecciona entre hidroxi, alcoxi, -X2-(CX3)-(CR6R7)m-X2-(CX3)-R8, -X2-(CX3)-(CR6R7)m-R8, y -X2-(CX3)- (CR6R7)m-X2-R18; R6 y R7 se seleccionan independientemente entre hidrógeno, hidroxi, flúor, cloro y alquilo C1-C6; R8 se selecciona entre alquilo C1-C6, fluoroalquilo C1-C6, heterocicloalquilo, arilo, heteroarilo, alcoxi, ariloxi, cada uno de los anteriores está opcionalmente sustituido, hidroxi y -NR15R16; R15 y R16 se seleccionan independientemente entre hidrógeno y alquilo C1-C6; o R16 es COOR17; R17 es alquilo C1-C6; R18 se selecciona entre alquilo C1-C6, fluoroalquilo C1-C6, arilo y heteroarilo, cada uno de los cuales está opcionalmente sustituido; cada X2 se selecciona independientemente de O, S y NR15; X3 se selecciona entre O y S; R3 y R4 son independientemente un alquilo C1-C6; R5 se selecciona entre -(CR9R10)n-R11 y -(CR12=CR13)n-R14; R9 y R10 se seleccionan independientemente entre hidrógeno y alquilo C1-C6; o alternativamente R9 y R10, junto con el carbono al que están unidos, forman un cicloalquilo C3-C6; R11 y R14 se seleccionan independientemente entre alquilo C1-C6, cicloalquilo C3-C6, arilo y heteroarilo, cada uno de los cuales está opcionalmente sustituido; R12 y R13 se seleccionan independientemente entre hidrógeno, halógeno y alquilo C1-C6; X1 se selecciona entre O, NR15, y S; y n y m se seleccionan independientemente entre 0 y un número entero de 1 a 3, siempre que cuando ""a"" sea un enlace doble, R1 sea heterocicloalquilo, que está opcionalmente sustituido; en donde cuando uno o más de los radicales opcionalmente sustituidos anteriores están sustituidos, al menos un sustituyente se selecciona del grupo que consiste en halo, alquilo, alquenilo, alquinilo, hidroxi, nitro, ciano, amino, alquilamino, alcoxi, ariloxi, aralcoxi, carboxilo, carboxialquilo, carboxialquiloxi, amido, alquilamido, haloalquilamido, arilo, heteroarilo y heterocicloalquilo, o una de sus sales farmacéuticamente aceptables.",US HEALTH;;FUNDACIO INSTITUT CATALA DINVESTIGACIO QUIM;;UNIV DELAWARE;;UNIV LEEDS INNOVATIONS LTD;;UNIV ROVIRA I VIRGILI,BEUTLER JOHN;;ECHAVARREN ANTONIO;;CHAIN WILLIAM;;BEECH DAVID;;WU ZHENHUA;;SUPPO JEAN-SIMON;;BRAVO FERNANDO;;RUBAIY HUSSEIN,,https://lens.org/149-899-709-325-614,Granted Patent,no,0,0,11,11,0,C07D493/08;;A61P35/00;;C07D493/08;;C07D495/08;;C07D471/08,C07D493/08;;A61K31/35;;A61P35/00,,0,0,,,,ACTIVE
36,EP,A3,EP 0387860 A3,103-694-836-648-821,1991-10-16,1991,EP 90104853 A,1990-03-14,US 32364889 A,1989-03-15,ANTITUMOR ANTIBIOTIC BMY-41339,A novel antitumor antibiotic of formula (I) designated BMY-41339 is produced by fermentation of certain strains of Actinomadura verrucosospora. BMY-41339 exhibits antimicrobial activity and also inhibits the growth of tumors in experimental animals.,BRISTOL-MYERS SQUIBB COMPANY;;THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES,"GOLIK, JERZY;;BEUTLER, JOHN, DR.;;CLARK, PAT;;ROSS, JOHN;;ROACH, JOHN;;MUSCHIK, GARY;;LEBHERZ, WILLIAM B. III",,https://lens.org/103-694-836-648-821,Search Report,yes,1,0,7,8,0,C07H15/203;;C12P19/44;;A61P31/04;;A61P35/00;;A61P35/02;;C12R2001/03;;C12N1/205;;C07H15/203;;C12P19/44;;C12N1/205;;C12R2001/03,C12P19/56;;A61K31/70;;A61K31/7028;;A61K31/7034;;A61P31/04;;A61P35/00;;A61P35/02;;C07H15/203;;C12P19/44;;C12R1/03,,0,0,,,,DISCONTINUED
37,AU,B2,AU 2018/297271 B2,038-024-655-397-367,2022-06-30,2022,AU 2018/297271 A,2018-07-05,US 201762529063 P;;US 2018/0040910 W,2017-07-06,Englerin derivatives for treatment of cancer,"Disclosed is a compound of formula (I) in which a, R",FUNDACIO INSTITUT CATALA DINVESTIGACIO QUIM;;THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY;;UNIV ROVIRA I VIRGILI;;UNIV DELAWARE;;UNIV LEEDS INNOVATIONS LTD,BEUTLER JOHN A;;ECHAVARREN ANTONIO;;CHAIN WILLIAM;;WU ZHENHUA;;BEECH DAVID;;SUPPO JEAN-SIMON;;BRAVO FERNANDO;;RUBAIY HUSSEIN,,https://lens.org/038-024-655-397-367,Granted Patent,no,2,0,11,11,0,C07D493/08;;A61P35/00;;C07D493/08;;C07D495/08;;C07D471/08,C07D493/08;;A61K31/35;;A61P35/00,,2,2,003-896-755-951-896;;063-719-352-867-752,pmc4862412;;10.1016/j.bmcl.2016.04.016;;27107948;;27005578;;10.1002/cmdc.201600040;;pmc4926265,"D. M. FASH ET. AL.: ""Synthesis of a stable and orally bioavailable englerin analogue"", BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS, vol. 26, 8 April 2016, pages 2641 - 2644;;L. LOPEZ-SUAREZ ET. AL.: ""Synthesis and Biologivcal Evaluation of New (-)-Englerin Analogues."", CHEMMEDCHEM, vol. 11, 23 March 2016, pages 1003 - 1007",ACTIVE
38,EP,B1,EP 3649133 B1,052-106-158-196-579,2022-02-23,2022,EP 18745789 A,2018-07-05,US 201762529063 P;;US 2018/0040910 W,2017-07-06,ENGLERIN DERIVATIVES FOR TREATMENT OF CANCER,,US HEALTH;;FUNDACIO INSTITUT CATALA DINVESTIGACIO QUIM;;UNIV DELAWARE;;UNIV LEEDS INNOVATIONS LTD;;UNIV ROVIRA I VIRGILI,BEUTLER JOHN A;;ECHAVARREN ANTONIO;;CHAIN WILLIAM;;BEECH DAVID;;WU ZHENHUA;;SUPPO JEAN-SIMON;;BRAVO FERNANDO;;RUBAIY HUSSEIN,"UNIVERSITY OF LEEDS (2021-10-06);;THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (2021-10-06);;UNIVERSITAT ROVIRA I VIRGILI (2021-10-06);;FUNDACIO INSTITUT CATALA D'INVESTIGACIO QUIMICA (2021-10-06);;UNIVERSITY OF DELAWARE (2021-10-06)",https://lens.org/052-106-158-196-579,Granted Patent,yes,2,0,11,11,0,C07D493/08;;A61P35/00;;C07D493/08;;C07D495/08;;C07D471/08,C07D493/08;;A61K31/35;;A61P35/00,,2,0,,,"D. M. FASH ET. AL.: ""Synthesis of a stable and orally bioavailable englerin analogue"", BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS, vol. 26, 8 April 2016 (2016-04-08), pages 2641-2644, XP002784084, DOI: 10.1016/j.bcml.2016.04.016;;L. LOPEZ-SUAREZ ET. AL.: ""Synthesis and Biologivcal Evaluation of New (-)-Englerin Analogues."", CHEMMEDCHEM, vol. 11, 23 March 2016 (2016-03-23), pages 1003-1007, XP002784085, DOI: 10.1002/cmdc.201600040",ACTIVE
39,AU,A1,AU 2018/297271 A1,037-502-654-162-678,2020-01-30,2020,AU 2018/297271 A,2018-07-05,US 201762529063 P;;US 2018/0040910 W,2017-07-06,Englerin derivatives for treatment of cancer,,FUNDACIO INSTITUT CATALA DINVESTIGACIO QUIM;;THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY;;UNIV ROVIRA I VIRGILI;;UNIV DELAWARE;;UNIV LEEDS INNOVATIONS LTD,BEUTLER JOHN A;;ECHAVARREN ANTONIO;;CHAIN WILLIAM;;WU ZHENHUA;;BEECH DAVID;;SUPPO JEAN-SIMON;;BRAVO FERNANDO;;RUBAIY HUSSEIN,,https://lens.org/037-502-654-162-678,Patent Application,no,0,0,11,11,0,C07D493/08;;A61P35/00;;C07D493/08;;C07D495/08;;C07D471/08,C07D493/08;;A61K31/35;;A61P35/00,,0,0,,,,ACTIVE
40,CA,A1,CA 3068980 A1,144-875-397-417-377,2019-01-10,2019,CA 3068980 A,2018-07-05,US 201762529063 P;;US 2018/0040910 W,2017-07-06,ENGLERIN DERIVATIVES FOR TREATMENT OF CANCER,"Disclosed is a compound of formula (I) in which a, R1- R5 and X1 are as described herein. Also disclosed are a pharmaceutical composition containing the compound and a method of using the compound for treating cancer, such as renal cancer.",US HEALTH;;FUNDACIO INSTITUT CATALA DINVESTIGACIO QUIM;;UNIV DELAWARE;;UNIV LEEDS INNOVATIONS LTD;;UNIV ROVIRA I VIRGILI,BEUTLER JOHN A;;ECHAVARREN ANTONIO;;CHAIN WILLIAM;;BEECH DAVID;;WU ZHENHUA;;SUPPO JEAN-SIMON;;BRAVO FERNANDO;;RUBAIY HUSSEIN,,https://lens.org/144-875-397-417-377,Patent Application,no,0,0,11,11,0,C07D493/08;;A61P35/00;;C07D493/08;;C07D495/08;;C07D471/08,C07D493/08;;A61K31/35;;A61P35/00,,0,0,,,,PENDING
41,US,A1,US 2020/0140451 A1,113-380-023-021-977,2020-05-07,2020,US 201816628768 A,2018-07-05,US 201816628768 A;;US 201762529063 P;;US 2018/0040910 W,2017-07-06,ENGLERIN DERIVATIVES FOR TREATMENT OF CANCER,"Disclosed is a compound of formula (I) in which a, R 1 -R 5 and X 1 are as described herein. Also disclosed are a pharmaceutical composition containing the compound and a method of using the compound for treating cancer, such as renal cancer.",US HEALTH;;FUNDACIO INSTITUT CATALA DINVESTIGACIO QUIM;;UNIV DELAWARE;;UNIV LEEDS INNOVATIONS LTD;;UNIV ROVIRA I VIRGILI,BEUTLER JOHN A;;ECHAVARREN ANTONIO;;CHAIN WILLIAM;;BEECH DAVID;;WU ZHENHUA;;SUPPO JEAN-SIMON;;BRAVO FERNANDO;;RUBAIY HUSSEIN,UNIVERSITY OF LEEDS (2020-02-20);;THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES (2020-02-24);;UNIVERSITAT ROVIRA I VIRGILI (2020-02-17);;FUNDACIÓ INSTITUT CATALÀ D'INVESTIGACIÓ QUÍMICA (2020-02-14);;UNIVERSITY OF DELAWARE (2018-11-21),https://lens.org/113-380-023-021-977,Patent Application,yes,0,0,11,11,0,C07D493/08;;A61P35/00;;C07D493/08;;C07D495/08;;C07D471/08,C07D493/08;;A61P35/00,,0,0,,,,ACTIVE
42,EP,A1,EP 3649133 A1,093-819-103-637-071,2020-05-13,2020,EP 18745789 A,2018-07-05,US 201762529063 P;;US 2018/0040910 W,2017-07-06,ENGLERIN DERIVATIVES FOR TREATMENT OF CANCER,,US HEALTH;;FUNDACIO INSTITUT CATALA DINVESTIGACIO QUIM;;UNIV DELAWARE;;UNIV LEEDS INNOVATIONS LTD;;UNIV ROVIRA I VIRGILI,BEUTLER JOHN A;;ECHAVARREN ANTONIO;;CHAIN WILLIAM;;BEECH DAVID;;WU ZHENHUA;;SUPPO JEAN-SIMON;;BRAVO FERNANDO;;RUBAIY HUSSEIN,"UNIVERSITY OF LEEDS (2021-10-06);;THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (2021-10-06);;UNIVERSITAT ROVIRA I VIRGILI (2021-10-06);;FUNDACIO INSTITUT CATALA D'INVESTIGACIO QUIMICA (2021-10-06);;UNIVERSITY OF DELAWARE (2021-10-06)",https://lens.org/093-819-103-637-071,Patent Application,yes,0,0,11,11,0,C07D493/08;;A61P35/00;;C07D493/08;;C07D495/08;;C07D471/08,C07D493/08;;A61K31/35;;A61P35/00,,0,0,,,,ACTIVE
43,US,B2,US 11098054 B2,155-086-954-011-706,2021-08-24,2021,US 201816628768 A,2018-07-05,US 201816628768 A;;US 201762529063 P;;US 2018/0040910 W,2017-07-06,Englerin derivatives for treatment of cancer,"Disclosed is a compound of formula (I) in which a, R 1 -R 5 and X 1 are as described herein. Also disclosed are a pharmaceutical composition containing the compound and a method of using the compound for treating cancer, such as renal cancer.",US HEALTH;;FUNDACIO INSTITUT CATALA DINVESTIGACIO QUIM;;UNIV DELAWARE;;UNIV LEEDS INNOVATIONS LTD;;UNIV ROVIRA I VIRGILI;;THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SCIENCES,BEUTLER JOHN A;;ECHAVARREN ANTONIO;;CHAIN WILLIAM;;BEECH DAVID;;WU ZHENHUA;;SUPPO JEAN-SIMON;;BRAVO FERNANDO;;RUBAIY HUSSEIN,UNIVERSITY OF LEEDS (2020-02-20);;THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES (2020-02-24);;UNIVERSITAT ROVIRA I VIRGILI (2020-02-17);;FUNDACIÓ INSTITUT CATALÀ D'INVESTIGACIÓ QUÍMICA (2020-02-14);;UNIVERSITY OF DELAWARE (2018-11-21),https://lens.org/155-086-954-011-706,Granted Patent,yes,8,0,11,11,0,C07D493/08;;A61P35/00;;C07D493/08;;C07D495/08;;C07D471/08,C07D493/08;;A61P35/00;;C07D471/08;;C07D495/08,,25,20,028-084-225-360-902;;003-896-755-951-896;;088-303-716-893-811;;058-482-345-033-756;;079-770-028-201-89X;;097-960-504-706-574;;002-567-009-774-230;;003-896-755-951-896;;060-664-176-278-726;;063-719-352-867-752;;013-922-466-066-291;;049-206-013-162-853;;014-391-185-229-644;;155-216-573-885-111;;035-973-322-568-362;;033-313-295-307-397;;124-141-343-853-394;;078-433-256-600-151;;049-355-702-780-082;;049-355-702-780-082,28170253;;10.1021/acs.jnatprod.6b01167;;pmc6198806;;pmc4862412;;10.1016/j.bmcl.2016.04.016;;27107948;;pmc7116557;;25707820;;10.1002/anie.201411511;;10.1021/np200905u;;22280462;;pmc3311709;;18759485;;10.1021/jo8014769;;10.1371/journal.pone.0127498;;26098886;;pmc4476799;;21360817;;10.1002/cmdc.201000544;;pmc4862412;;10.1016/j.bmcl.2016.04.016;;27107948;;27289383;;pmc5045487;;10.1007/s00249-016-1142-1;;27005578;;10.1002/cmdc.201600040;;pmc4926265;;27875305;;pmc5241745;;10.1074/jbc.m116.755678;;10.1002/anie.201000890;;20544903;;29209034;;10.1038/s41598-017-17303-3;;pmc5717101;;10.1021/ja102927n;;20496885;;21472928;;10.1002/anie.201007790;;19061394;;pmc2651161;;10.1021/ol802339w;;10.1021/jo801365z;;18698826;;22415793;;10.1002/asia.201101021;;pmc3338859;;32944138;;10.1021/acsmedchemlett.0c00186;;pmc7488277;;10.1021/acsmedchemlett.0c00186.s001;;32944138;;10.1021/acsmedchemlett.0c00186;;pmc7488277;;10.1021/acsmedchemlett.0c00186.s001,"Wu (“Englerins: A Comprehensive Review” J. Nat. Prod. 2017, 80, p. 771-781, including Supporting Information p. S1-S21) (Year: 2017).;;Fash (“Synthesis of a stable and orally bioavailable englerin analogue” Bioorganic and Medicinal Chemistry Letters, 26, 2016, p. 2641-2644) (Year: 2016).;;Akbulut et al., “(−)-Englerin A is a Potent and Selective Activator of TRPC4 and TRPC5 Calcium Channels,” Angew. Chem. Int. Ed. Engl., 54(12): 3787-3791 (2015).;;Akee et al. “Chlorinated Englerins With Selective Inhibition of Renal Cancer Cell Growth,” J. Nat. Prod., 75(3): 459-463 (2012).;;Amijs et al., “Gold(I)-Catalyzed Intermolecular Addition of Carbon Nucleophiles to 1,5- and 1,6-Enynes,” J. Org. Chem., 73(19): 7721-7730 (2008).;;Carson et al., “Englerin A agonizes the TRPC4/C5 cation channels to inhibit tumor cell line proliferation,” PLoS One, 10(6): e0127498 (2015).;;Chan et al., “Chemical Synthesis and Biological Evaluation of the Englerin Analogues,” ChemMedChem., 6(3): 420-423 (2011).;;Fash et al., “Synthesis of a stable and orally bioavailable englerin analogue,” Bioorg. Med. Chem. Lett., 26(11): 2641-2644 (2016).;;Gaunt et al., “Transient receptor potential canonical 4 and 5 proteins as targets in cancer therapeutics,” Eur. Biophys. J., 45(7): 611-620 (2016).;;López-Suarez et al., “Synthesis and biological evaluation of new (−)-englerin analogues,” ChemMedChem., 11(9): 1003-1007 (2016).;;Ludlow et al., “(−)-Englerin A-evoked cytotoxicity is mediated by Na+ influx and counteracted by Na+/K+-ATPase,” J. Biol. Chem., 292(2): 723-731 (2016).;;Molawi et al., “Enantioselective Synthesis of (−)-Englerins A and B,” Angew. Chem. Int. Ed., 49(20): 3517-3519 (2010).;;Muraki et al., “Na+ Entry Through Heteromeric TRPC4/C1 Channels Mediates (−)Englerin A-induced Cytotoxicity in Synovial Sarcoma Cells,” Scientific Reports, 7(1): 16988 (2017).;;Nakatsuji et al., “General, Robust, and Stereocomplementary Preparation of β-Ketoester Enol Tosylates as Cross-Coupling Partners Utilizing TsCl-N-Methylimidazole Agents,” Org. Lett., 10(11): 2131-2134 (2008).;;Nicolaou et al., “Total Synthesis of Englerin A,” J. Am. Chem. Soc., 132(23): 8219-8222 (2010).;;Radtke et al., “Total Synthesis and Biological Evaluation of (−)-Englerin A and B: Synthesis of Analogues with Improved Activity Profile,” Angew. Chem. Int. Ed., 50(17): 3998-4002 (2011).;;Ratnayake et al., “Englerin A, a Selective Inhibitor of Renal Cancer Cell Growth, from Phyllanthus engleri,” Organic Letters, 11(1): 57-60 (2009).;;Riou et al., “De Novo Synthesis of (+)-Isofregenedol,” J. Org. Chem., 73(18): 7436-7439 (2008).;;Sourbier et al., “Englerin A Stimulates PKCθ to Inhibit Insulin Signaling and to Simultaneously Activate HSF1: Pharmacologically Induced Synthetic Lethality,” Cancer Cell, 23(2): 228-237 (2013).;;Xu et al., “Formal Synthesis of (−)-Englerin A and Cytotoxicity Studies of Truncated Englerins,” Chem. Asian J., 7(5): 1052-1060 (2012).;;European Patent Office, International Preliminary Report on Patentability in International Patent Application No. PCT/US2018/040910 (dated Jan. 16, 2020).;;European Patent Office, International Search Report in International Patent Application No. PCT/US2018/040910 (dated Sep. 5, 2018).;;European Patent Office, Written Opinion of the International Searching Authority in International Patent Application No. PCT/US2018/040910 (dated Sep. 5, 2018).;;Wu et al., “Bridgehead Modifications of Englerin A Reduce TRPC4 Activity and Intravenous Toxicity but not Cell Growth Inhibition,” ACS Med. Chem. Lett., 11(9): 1711-1716 (2020).;;Wu et al., “Bridgehead Modifications of Englerin A Reduce TRPC4 Activity and Intravenous Toxicity but not Cell Growth Inhibition,” ACS Med. Chem. Lett., Supporting Information, pp. 1-123 (2020).",ACTIVE
44,US,B2,US 8211012 B2,034-981-993-988-812,2012-07-03,2012,US 24189708 A,2008-09-30,US 24189708 A,2008-09-30,Tissue retractor system,"A tissue retractor system includes first and second arms extending from a support assembly, and third and fourth arms extending from a support mechanism. Each arm includes a proximal span, a distal span, and a blade support between the proximal span and distal span. The retractor system features retractor units that can be used independently or in a nested arrangement. The system also includes instruments for inserting a spinal rod. A method for implanting a spinal rod through an incision includes the steps of inserting the spinal rod through a dividable tube, turning the rod subcutaneously toward a rod receiving anchor and advancing the rod subcutaneously toward the rod receiving anchor.",WING CHARLES;;BEUTLER WILLIAM J;;MCMURRAY WALTER J;;BUSS DONALD A;;HUGHETT JAMES DAVID;;TOMPKINS JEFFREY S;;COLE JEFFREY;;AESCULAP IMPLANT SYSTEMS LLC,WING CHARLES;;BEUTLER WILLIAM J;;MCMURRAY WALTER J;;BUSS DONALD A;;HUGHETT JAMES DAVID;;TOMPKINS JEFFREY S;;COLE JEFFREY,AESCULAP IMPLANT SYSTEMS LLC (2008-11-21),https://lens.org/034-981-993-988-812,Granted Patent,yes,107,24,5,5,0,A61B17/0206;;A61B17/0218;;A61B17/7076;;A61B17/7083;;A61B17/7085;;A61B17/0206;;A61B17/0218;;A61B17/7076;;A61B17/7083;;A61B17/7085,A61B1/32,600/215;;600/233;;600/210,2,0,,,"H. Michael Myer, MD, Aesculap Spine, miaspas mini TTA, Microsurgical Anterior, 2007, pp. 1-27.;;European Search Report for Application No. EP 09 17 1234; Search Completed Jan. 22, 2010.",INACTIVE
45,US,A1,US 2010/0081885 A1,036-418-472-715-157,2010-04-01,2010,US 24189708 A,2008-09-30,US 24189708 A,2008-09-30,TISSUE RETRACTOR SYSTEM,"A tissue retractor system includes first and second arms extending from a support assembly, and third and fourth arms extending from a support mechanism. Each arm includes a proximal span, a distal span, and a blade support between the proximal span and distal span. The retractor system features retractor units that can be used independently or in a nested arrangement. The system also includes instruments for inserting a spinal rod. A method for implanting a spinal rod through an incision includes the steps of inserting the spinal rod through a dividable tube, turning the rod subcutaneously toward a rod receiving anchor and advancing the rod subcutaneously toward the rod receiving anchor.",AESCULAP IMPLANT SYSTEMS INC,WING CHARLES;;BEUTLER WILLIAM J;;MCMURRAY WALTER J;;COLE JEFFREY;;BUSS DONALD A;;HUGHETT JAMES DAVID;;TOMPKINS JEFFREY S,AESCULAP IMPLANT SYSTEMS LLC (2008-11-21),https://lens.org/036-418-472-715-157,Patent Application,yes,95,42,5,5,0,A61B17/0206;;A61B17/0218;;A61B17/7076;;A61B17/7083;;A61B17/7085;;A61B17/0206;;A61B17/0218;;A61B17/7076;;A61B17/7083;;A61B17/7085,A61B1/32,600/215,0,0,,,,INACTIVE
46,WO,A3,WO 2010/047947 A3,158-791-775-504-743,2011-02-03,2011,US 2009/0059766 W,2009-10-07,US 25687508 A,2008-10-23,DIFFERENTIAL LUBRICATION FEED SYSTEM IN A DRIVE AXLE ASSEMBLY,A method for lubricating an axle assembly can include: coupling a pair of tapered roller bearing to opposite ends of a differential housing; placing the differential housing into a carrier housing assembly such that the tapered roller bearings support the differential housing on the carrier housing assembly for rotation about a first axis; collecting a lubricant proximate a side of one of the tapered roller bearings opposite the differential housing; and rotating the differential housing about the first axis to cause the one of the tapered roller bearings to move a portion of the collected lubricant through the differential housing. A related axle assembly is also provided.,AMERICAN AXLE & MFG INC;;HILKER GREGORY J;;BEUTLER KEVIN R;;DWYER ROBERT B;;CHUNG CHIH-HUNG;;BRANDT DAVID R;;HUNT WILLIAM G;;WOODSIDE GREGORY E,HILKER GREGORY J;;BEUTLER KEVIN R;;DWYER ROBERT B;;CHUNG CHIH-HUNG;;BRANDT DAVID R;;HUNT WILLIAM G;;WOODSIDE GREGORY E,,https://lens.org/158-791-775-504-743,Search Report,no,4,0,7,7,0,F16H57/0424;;F16H57/0471;;F16H57/0483;;F16H2048/423;;F16H2048/423;;F16H57/0471;;F16H57/0424;;F16H57/0483;;F16H48/38,F16H57/04;;F16H48/00,,0,0,,,,PENDING
47,DE,T5,DE 112009002476 T5,170-782-638-482-277,2013-02-07,2013,DE 112009002476 T,2009-10-07,US 25687508 A;;US 2009/0059766 W,2008-10-23,Einspeisungssystem für Differentialgetriebeschmiermittel in einer Antriebsachsanordnung,"Verfahren zum Schmieren einer Achsanordnung, das umfassen kann: Verbinden eines Paars von Kegelrollenlagern mit gegenüberliegenden Enden eines Differentialkorbs; Anordnen des Differentialkorbs in einer Trägergehäuseanordnung, so dass die Kegelrollenlager den Differentialkorb bei einer Drehung um eine erste Achse an dem Trägergehäuse abstützen; Sammm der Kegelrollenlager, die dem Differentialkorb gegenüber liegt; und Drehen des Differentialkorbs um die erste Achse, um zu bewirken, dass das eine der Kegelrollenlager einen Teil des gesammelten Schmiermittels durch den Differentialkorb bewegt. Eine zugehörige Achsanordnung ist ebenso vorgesehen.",AMERICAN AXLE & MFG INC,BEUTLER KEVIN R;;DWYER ROBERT B;;CHUNG CHIH-HUNG;;BRANDT DAVID R;;HUNT WILLIAM G;;WOODSIDE GREGORY E;;HILKER GREGORY J,,https://lens.org/170-782-638-482-277,Patent Application,no,2,0,7,7,0,F16H57/0424;;F16H57/0471;;F16H57/0483;;F16H2048/423;;F16H2048/423;;F16H57/0471;;F16H57/0424;;F16H57/0483;;F16H48/38,F16H57/04;;F16H48/00,,0,0,,,,PENDING
48,CA,A1,CA 2012013 A1,195-351-825-919-000,1990-09-15,1990,CA 2012013 A,1990-03-13,US 32364889 A,1989-03-15,ANTITUMOR ANTIBIOTIC BMY-41339,,BRISTOL MYERS SQUIBB CO;;US HEALTH,GOLIK JERZY;;CLARK PATRICK K;;ROACH JOHN M;;BEUTLER JOHN A;;ROSS JOHN T;;MUSCHIK GARY M;;LEBHERZ WILLIAM B III,,https://lens.org/195-351-825-919-000,Patent Application,no,0,0,7,8,0,C07H15/203;;C12P19/44;;A61P31/04;;A61P35/00;;A61P35/02;;C12R2001/03;;C12N1/205;;C07H15/203;;C12P19/44;;C12N1/205;;C12R2001/03,C12P19/56;;A61K31/70;;A61K31/7028;;A61K31/7034;;A61P31/04;;A61P35/00;;A61P35/02;;C07H15/203;;C12P19/44;;C12R1/03,D31950096    M;;260023058  S;;1670185    S,0,0,,,,EXPIRED
49,US,A1,US 2010/0105513 A1,177-232-050-414-474,2010-04-29,2010,US 25687508 A,2008-10-23,US 25687508 A,2008-10-23,DIFFERENTIAL LUBRICATION FEED SYSTEM IN A DRIVE AXLE ASSEMBLY,A method for lubricating an axle assembly can include: coupling a pair of tapered roller bearing to opposite ends of a differential housing; placing the differential housing into a carrier housing assembly such that the tapered roller bearings support the differential housing on the carrier housing assembly for rotation about a first axis; collecting a lubricant proximate a side of one of the tapered roller bearings opposite the differential housing; and rotating the differential housing about the first axis to cause the one of the tapered roller bearings to move a portion of the collected lubricant through the differential housing. A related axle assembly is also provided.,HILKER GREGORY J;;BEUTLER KEVIN R;;DWYER ROBERT B;;CHUNG CHIH-HUNG;;BRANDT DAVID R;;HUNT WILLIAM G;;WOODSIDE GREGORY E,HILKER GREGORY J;;BEUTLER KEVIN R;;DWYER ROBERT B;;CHUNG CHIH-HUNG;;BRANDT DAVID R;;HUNT WILLIAM G;;WOODSIDE GREGORY E,AMERICAN AXLE & MANUFACTURING INC (2008-10-15),https://lens.org/177-232-050-414-474,Patent Application,yes,56,19,7,7,0,F16H57/0424;;F16H57/0471;;F16H57/0483;;F16H2048/423;;F16H2048/423;;F16H57/0471;;F16H57/0424;;F16H57/0483;;F16H48/38,F16H57/04,475/160,0,0,,,,ACTIVE
50,WO,A2,WO 2010/047947 A2,159-763-122-253-594,2010-04-29,2010,US 2009/0059766 W,2009-10-07,US 25687508 A,2008-10-23,DIFFERENTIAL LUBRICATION FEED SYSTEM IN A DRIVE AXLE ASSEMBLY,A method for lubricating an axle assembly can include: coupling a pair of tapered roller bearing to opposite ends of a differential housing; placing the differential housing into a carrier housing assembly such that the tapered roller bearings support the differential housing on the carrier housing assembly for rotation about a first axis; collecting a lubricant proximate a side of one of the tapered roller bearings opposite the differential housing; and rotating the differential housing about the first axis to cause the one of the tapered roller bearings to move a portion of the collected lubricant through the differential housing. A related axle assembly is also provided.,AMERICAN AXLE & MFG INC;;HILKER GREGORY J;;BEUTLER KEVIN R;;DWYER ROBERT B;;CHUNG CHIH-HUNG;;BRANDT DAVID R;;HUNT WILLIAM G;;WOODSIDE GREGORY E,HILKER GREGORY J;;BEUTLER KEVIN R;;DWYER ROBERT B;;CHUNG CHIH-HUNG;;BRANDT DAVID R;;HUNT WILLIAM G;;WOODSIDE GREGORY E,,https://lens.org/159-763-122-253-594,Patent Application,yes,0,0,7,7,0,F16H57/0424;;F16H57/0471;;F16H57/0483;;F16H2048/423;;F16H2048/423;;F16H57/0471;;F16H57/0424;;F16H57/0483;;F16H48/38,,,0,0,,,,PENDING
51,CA,C,CA 2012013 C,139-280-491-806-05X,1995-08-22,1995,CA 2012013 A,1990-03-13,US 32364889 A,1989-03-15,ANTITUMOR ANTIBIOTIC BMY-41339,A novel antitumor antibiotic designated BMY-41339 is produced by fermentation of certain strains of Actinomadura verrucosospora. BMY-41339 exhibits antimicrobial activity and also inhibits the growth of tumors in expetimental animals.,BRISTOL MYERS SQUIBB CO;;US HEALTH,GOLIK JERZY;;CLARK PATRICK K;;ROACH JOHN M;;BEUTLER JOHN A;;ROSS JOHN T;;MUSCHIK GARY M;;LEBHERZ WILLIAM B III,,https://lens.org/139-280-491-806-05X,Granted Patent,no,0,0,7,8,0,C07H15/203;;C12P19/44;;A61P31/04;;A61P35/00;;A61P35/02;;C12R2001/03;;C12N1/205;;C07H15/203;;C12P19/44;;C12N1/205;;C12R2001/03,C12P19/56;;A61K31/70;;A61K31/7028;;A61K31/7034;;A61P31/04;;A61P35/00;;A61P35/02;;C07H15/203;;C12P19/44;;C12R1/03,D31950096    M;;1670185    S;;260023058  S,0,0,,,,EXPIRED
52,US,B2,US 8409044 B2,075-729-303-152-739,2013-04-02,2013,US 25687508 A,2008-10-23,US 25687508 A,2008-10-23,Differential lubrication feed system in a drive axle assembly,A method for lubricating an axle assembly can include: coupling a pair of tapered roller bearing to opposite ends of a differential housing; placing the differential housing into a carrier housing assembly such that the tapered roller bearings support the differential housing on the carrier housing assembly for rotation about a first axis; collecting a lubricant proximate a side of one of the tapered roller bearings opposite the differential housing; and rotating the differential housing about the first axis to cause the one of the tapered roller bearings to move a portion of the collected lubricant through the differential housing. A related axle assembly is also provided.,HILKER GREGORY J;;BEUTLER KEVIN R;;DWYER ROBERT B;;CHUNG CHIH-HUNG;;BRANDT DAVID R;;HUNT WILLIAM G;;WOODSIDE GREGORY E;;AMERICAN AXLE & MFG INC,HILKER GREGORY J;;BEUTLER KEVIN R;;DWYER ROBERT B;;CHUNG CHIH-HUNG;;BRANDT DAVID R;;HUNT WILLIAM G;;WOODSIDE GREGORY E,AMERICAN AXLE & MANUFACTURING INC (2008-10-15),https://lens.org/075-729-303-152-739,Granted Patent,yes,59,17,7,7,0,F16H57/0424;;F16H57/0471;;F16H57/0483;;F16H2048/423;;F16H2048/423;;F16H57/0471;;F16H57/0424;;F16H57/0483;;F16H48/38,F16H57/04,475/160,1,0,,,"International Search Report and Written Opinion of the International Searching Authority for International Application No. PCT/US2009/059766, dated Dec. 9, 2010.",ACTIVE
53,WO,A1,WO 2022/055962 A1,090-585-069-887-158,2022-03-17,2022,US 2021/0049414 W,2021-09-08,US 202017017056 A;;US 201962898836 P,2019-09-11,FAR BONE SUTURE BUTTON,"Suture buttons are disclosed for fixing two bones together. The suture buttons may enable surgeons to more easily and effectively implement the suture button technique, such as to repair syndesmosis injuries in ankles. A first suture button includes a pulley peg extending from a button head. The pulley peg may be positioned with a bone hole upon installation of the first suture button, which may help protect suture and help reduce potential patient discomfort. The second suture button helps facilitate the second suture button flipping into place upon deployment from a button inserter. Each of the first and second provided suture buttons may help reduce friction between the respective buttons and suture during an installation procedure. The first and second provided suture buttons may be used together in a surgical procedure or individually with other suitable buttons or anchors.",ACUMED LLC,FEDERSPIEL JOSHUA P;;VANVLEET DAVID;;MORGAN STEVEN;;PAREKH SELENE;;YOUNGER ALASTAIR;;SOMMERS MARK B;;HINTON GRETCHEN;;SANTICH ANN;;BEUTLER JR WILLIAM A,,https://lens.org/090-585-069-887-158,Patent Application,yes,4,0,11,11,0,A61B17/683;;A61B2017/0404;;A61B17/0401;;A61B2017/0409;;A61B2017/0496;;A61B2017/0417;;A61B17/0401;;A61B2017/0404;;A61B2017/681;;A61B17/683;;A61B2017/00367;;A61B2017/0409,A61B17/04;;A61B17/03;;A61B17/68,,0,0,,,,PENDING
54,US,B2,US 11744572 B2,134-462-627-466-812,2023-09-05,2023,US 202017017056 A,2020-09-10,US 202017017056 A;;US 201962898836 P,2019-09-11,Far bone suture button,"Suture buttons are disclosed for fixing two bones together. The suture buttons may enable surgeons to more easily and effectively implement the suture button technique, such as to repair syndesmosis injuries in ankles. A first suture button includes a pulley peg extending from a button head. The pulley peg may be positioned with a bone hole upon installation of the first suture button, which may help protect suture and help reduce potential patient discomfort. The second suture button helps facilitate the second suture button flipping into place upon deployment from a button inserter. Each of the first and second provided suture buttons may help reduce friction between the respective buttons and suture during an installation procedure. The first and second provided suture buttons may be used together in a surgical procedure or individually with other suitable buttons or anchors.",ACUMED LLC,FEDERSPIEL JOSHUA P;;VANVLEET DAVID;;MORGAN STEVEN;;PAREKH SELENE;;YOUNGER ALASTAIR;;SOMMERS MARK B;;HINTON GRETCHEN;;SANTICH ANN;;BEUTLER JR WILLIAM A,ACUMED LLC (2020-09-30),https://lens.org/134-462-627-466-812,Granted Patent,yes,9,0,11,11,0,A61B17/683;;A61B2017/0404;;A61B17/0401;;A61B2017/0409;;A61B2017/0496;;A61B2017/0417;;A61B17/0401;;A61B2017/0404;;A61B2017/681;;A61B17/683;;A61B2017/00367;;A61B2017/0409,A61B17/04;;A61B17/00;;A61B17/68,,6,0,,,"International Search Report corresponding to related International Patent Application No. PCT/US2021/049446 dated Dec. 22, 2021, 3 pages.;;International Written Opinion corresponding to related International Patent Application No. PCT/US2021/049446 dated Dec. 22, 2021, 10 pages.;;International Search Report corresponding to related International Patent Application No. PCT/US2021/049414 dated Dec. 14, 2021, 3 pages.;;International Written Opinion corresponding to related International Patent Application No. PCT/US2021/049414 dated Dec. 14, 2021, 8 pages.;;International Preliminary Report corresponding to related International Patent Application No. PCT/US2021/049414 dated Mar. 23, 2023, 10 pages.;;International Preliminary Report corresponding to related International Patent Application No. PCT/US2021/049446 dated Mar. 23, 2023, 8 pages.",ACTIVE
55,US,A1,US 2021/0068810 A1,020-536-014-537-433,2021-03-11,2021,US 202017017056 A,2020-09-10,US 202017017056 A;;US 201962898836 P,2019-09-11,FAR BONE SUTURE BUTTON,"Suture buttons are disclosed for fixing two bones together. The suture buttons may enable surgeons to more easily and effectively implement the suture button technique, such as to repair syndesmosis injuries in ankles. A first suture button includes a pulley peg extending from a button head. The pulley peg may be positioned with a bone hole upon installation of the first suture button, which may help protect suture and help reduce potential patient discomfort. The second suture button helps facilitate the second suture button flipping into place upon deployment from a button inserter. Each of the first and second provided suture buttons may help reduce friction between the respective buttons and suture during an installation procedure. The first and second provided suture buttons may be used together in a surgical procedure or individually with other suitable buttons or anchors.",ACUMED LLC,FEDERSPIEL JOSHUA P;;VANVLEET DAVID;;MORGAN STEVEN;;PAREKH SELENE;;YOUNGER ALASTAIR;;SOMMERS MARK B;;HINTON GRETCHEN;;SANTICH ANN;;BEUTLER JR WILLIAM A,ACUMED LLC (2020-09-30),https://lens.org/020-536-014-537-433,Patent Application,yes,1,1,11,11,0,A61B17/683;;A61B2017/0404;;A61B17/0401;;A61B2017/0409;;A61B2017/0496;;A61B2017/0417;;A61B17/0401;;A61B2017/0404;;A61B2017/681;;A61B17/683;;A61B2017/00367;;A61B2017/0409,A61B17/04,,0,0,,,,ACTIVE
56,US,A1,US 2023/0355230 A1,084-705-682-768-022,2023-11-09,2023,US 202318222753 A,2023-07-17,US 202318222753 A;;US 202017017056 A;;US 201962898836 P,2019-09-11,FAR BONE SUTURE BUTTON,"Suture buttons are disclosed for fixing two bones together. The suture buttons may enable surgeons to more easily and effectively implement the suture button technique, such as to repair syndesmosis injuries in ankles. A first suture button includes a pulley peg extending from a button head. The pulley peg may be positioned with a bone hole upon installation of the first suture button, which may help protect suture and help reduce potential patient discomfort. The second suture button helps facilitate the second suture button flipping into place upon deployment from a button inserter. Each of the first and second provided suture buttons may help reduce friction between the respective buttons and suture during an installation procedure. The first and second provided suture buttons may be used together in a surgical procedure or individually with other suitable buttons or anchors.",ACUMED LLC,FEDERSPIEL JOSHUA P;;VANVLEET DAVID;;MORGAN STEVEN;;PAREKH SELENE;;YOUNGER ALASTAIR;;SOMMERS MARK B;;HINTON GRETCHEN;;SANTICH ANN;;BEUTLER JR WILLIAM A,ACUMED LLC (2020-09-30),https://lens.org/084-705-682-768-022,Patent Application,yes,0,0,11,11,0,A61B17/683;;A61B2017/0404;;A61B17/0401;;A61B2017/0409;;A61B2017/0496;;A61B2017/0417;;A61B17/0401;;A61B2017/0404;;A61B2017/681;;A61B17/683;;A61B2017/00367;;A61B2017/0409,A61B17/04;;A61B17/68,,0,0,,,,PENDING
57,EP,A1,EP 4210592 A1,089-645-933-904-78X,2023-07-19,2023,EP 21867493 A,2021-09-08,US 202017017056 A;;US 2021/0049414 W;;US 201962898836 P,2019-09-11,FAR BONE SUTURE BUTTON,,ACUMED LLC,FEDERSPIEL JOSHUA P;;VANVLEET DAVID;;MORGAN STEVEN;;PAREKH SELENE;;YOUNGER ALASTAIR;;SOMMERS MARK B;;HINTON GRETCHEN;;SANTICH ANN;;BEUTLER JR WILLIAM A,,https://lens.org/089-645-933-904-78X,Patent Application,yes,0,0,11,11,0,A61B17/683;;A61B2017/0404;;A61B17/0401;;A61B2017/0409;;A61B2017/0496;;A61B2017/0417;;A61B17/0401;;A61B2017/0404;;A61B2017/681;;A61B17/683;;A61B2017/00367;;A61B2017/0409,A61B17/04;;A61B17/03;;A61B17/68,,0,0,,,,PENDING
